rfhg_81057.1

Basic information about the TSS

---

TSS ID: rfhg_81057.1 Species: human Chr: chr6		Start: 32175918 End: 32175926 Strand: -
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: Y09565:5 GeneID: 10554 HGNC/MGI_ID: HGNC:324 UniProt_ID: Nearer transcript ids and distances: AF218034:18 ENST00000476663.1:21 AK299252:-93 AK315950:-133 BC004310:-157 ENST00000375107.8:-158 NM_006411.4:-158 AK058025:-166 BC090849:-169 U56417:-190 view more...

Gene_name: 1-acylglycerol-3-phosphate O-acyltransferase 1 Gene_symbol: AGPAT1 Gene_synonyms: LPAAT-alpha LPLAT1 Gene_source: HGNC:324

TATA-Box annotation

---

Distance to TSS:	162
Nearest PromoterID:	NM_006411
Entrez ID:	10554
Nearest Unigene:	Hs.409230
Nearest Refseq:	NM_006411
Nearest Ensembl:	ENSG00000204310
Gene Name:	1-acylglycerol-3-phosphate O-acyltransferase 1
Gene Alias:	1-AGPAT1|G15|LPAAT-alpha|LPAATA
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	0.777778
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@AGPAT1 p2@AGPAT1 p3@AGPAT1 p4@AGPAT1 p5@AGPAT1 p6@AGPAT1 p7@AGPAT1 p8@AGPAT1 p9@AGPAT1
Sample		p1@AGPAT1	p2@AGPAT1	p3@AGPAT1	p4@AGPAT1	p5@AGPAT1	p6@AGPAT1	p7@AGPAT1	p8@AGPAT1	p9@AGPAT1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	12.86	0.19	1.95	2.53	0.78	1.17	2.53	0.00	0.19
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	13.76	0.40	1.01	1.42	1.42	2.02	2.02	0.00	0.61
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	14.66	0.96	1.74	2.51	0.96	1.54	2.51	0.00	0.19
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	9.56	0.21	1.46	1.46	0.62	2.08	1.66	0.00	0.21
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	10.35	0.00	1.57	0.90	1.12	0.22	1.35	0.00	0.45
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	9.50	0.39	1.94	1.74	0.97	0.58	1.74	0.00	0.58
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	17.87	0.44	1.74	3.05	0.65	1.74	3.05	0.00	0.65
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	13.08	0.24	0.97	1.94	0.24	0.97	2.42	0.00	0.48
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	15.17	0.00	0.85	2.78	0.85	0.85	1.07	0.21	0.64
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	9.27	0.00	1.16	0.58	1.16	0.58	1.16	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	9.30	0.40	1.21	0.00	0.40	0.40	0.00	0.00	0.40
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	6.10	0.00	0.41	1.22	0.81	0.41	0.81	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	17.73	0.64	1.45	1.29	0.81	0.81	2.74	0.16	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	13.68	2.26	2.41	0.90	2.10	0.75	1.65	0.30	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	13.39	1.54	1.10	0.66	1.32	0.88	1.10	0.00	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	11.07	1.26	0.75	3.27	0.25	1.51	2.01	0.00	0.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	7.43	1.53	0.87	1.09	0.66	0.87	2.18	0.22	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	10.97	1.27	1.69	2.95	1.69	1.27	6.75	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	10.66	1.07	2.67	0.53	0.00	0.53	2.13	0.00	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	12.19	1.05	1.20	2.56	1.65	0.60	2.41	0.15	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	15.77	1.20	1.20	2.27	0.67	0.94	1.74	0.13	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	13.46	0.86	0.69	2.24	1.90	1.04	1.55	0.00	1.04
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	11.89	1.55	2.33	1.55	1.29	1.29	1.81	0.26	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	10.92	0.97	0.97	1.46	1.21	0.73	1.70	0.00	0.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	13.67	2.06	1.29	2.32	1.03	0.77	2.58	0.26	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	13.61	0.32	0.95	1.90	1.90	0.95	1.27	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	9.34	1.10	0.55	1.65	0.55	2.20	3.30	0.55	1.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	17.45	1.89	1.65	0.94	1.65	0.24	1.41	0.00	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	10.82	0.65	0.81	1.78	1.29	1.13	2.10	0.00	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	10.86	1.09	0.72	1.09	1.63	0.36	2.53	0.00	0.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	7.75	0.42	1.05	2.51	0.42	1.26	1.67	0.00	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	11.14	0.39	0.78	2.93	0.39	0.59	1.76	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	10.76	0.42	1.27	2.11	1.48	0.84	3.38	0.42	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	12.37	1.98	1.32	2.14	1.98	1.15	1.98	0.00	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	10.28	0.56	2.43	1.12	0.56	1.12	3.18	0.19	0.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	11.50	0.38	1.15	1.15	0.77	0.96	1.72	0.00	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	11.85	0.41	1.64	1.43	0.82	0.20	1.43	0.20	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	7.25	1.01	1.01	1.81	1.41	1.21	0.60	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	15.67	1.89	0.81	1.08	0.81	1.62	2.16	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	12.48	0.48	1.44	0.24	0.48	0.48	1.44	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	11.53	0.94	1.65	0.94	0.94	0.94	1.41	0.00	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	8.78	0.88	0.15	2.20	0.73	1.61	1.90	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	12.44	1.27	0.42	1.90	1.48	1.05	1.48	0.00	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	12.06	1.05	0.00	2.62	1.22	0.52	2.27	0.00	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	13.65	2.01	1.61	1.20	0.20	1.00	1.20	0.20	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	14.66	0.47	0.47	1.86	0.93	0.93	2.33	0.00	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	11.52	0.48	0.96	1.44	0.48	0.72	0.72	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	8.05	0.89	0.60	2.38	0.30	0.30	0.60	0.00	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	10.77	0.96	0.72	1.20	0.96	0.96	1.91	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	13.14	0.81	0.81	1.01	0.40	0.20	0.81	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	11.68	1.02	0.20	2.46	0.82	0.82	1.23	0.20	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	12.23	1.11	0.89	1.78	0.67	0.67	3.34	0.00	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	13.99	83.95	13.99	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	5.32	0.35	2.13	1.77	1.42	0.71	1.06	0.00	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	6.30	0.99	0.99	1.33	1.33	0.99	1.99	0.00	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	11.75	7.55	1.68	5.03	1.68	2.52	8.39	0.00	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	10.10	1.84	0.00	3.67	0.46	1.38	2.76	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	4.54	0.00	0.65	1.94	0.32	1.94	1.94	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	9.31	0.00	0.64	1.28	0.64	1.28	1.93	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	12.57	0.00	0.94	2.20	1.26	0.63	5.34	0.00	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	2.82	2.12	0.00	0.71	0.71	1.41	0.71	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	7.29	0.00	0.56	0.56	1.68	2.24	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	41.40	8.76	2.39	11.15	0.80	0.80	5.57	0.80	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	13.59	0.68	0.34	3.06	0.00	0.00	4.42	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	9.42	1.30	0.00	3.25	0.32	1.30	2.60	0.32	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	6.74	0.00	0.71	0.71	0.35	1.42	2.13	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	0.00	145.48	0.00	0.00	32.33	0.00	16.16	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	23.69	78.97	7.90	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	5.85	1.46	0.00	1.46	0.00	2.44	2.44	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	5.95	0.99	0.50	1.98	0.00	1.49	1.49	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	12.67	0.94	1.88	0.94	0.47	0.94	2.81	0.00	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	11.26	1.99	0.99	2.32	0.66	0.33	5.96	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	5.57	1.24	0.62	0.93	0.62	2.47	1.86	0.31	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	7.34	0.61	0.61	0.31	0.00	1.83	1.83	0.00	0.00
Adipocyte - breast, donor1	11376-118A8	20.11	4.43	0.16	0.63	0.63	0.63	1.27	0.00	0.00
Adipocyte - breast, donor2	11327-117E4	18.93	0.80	0.48	3.05	0.32	1.12	2.41	0.32	0.16
Adipocyte - omental, donor1	11473-119C6	24.94	2.04	0.25	1.91	0.13	1.78	1.91	0.00	0.00
Adipocyte - omental, donor2	11474-119C7	12.71	0.00	0.00	1.49	0.00	2.24	0.00	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	15.74	1.34	0.00	2.68	0.00	1.00	0.00	0.00	0.00
Adipocyte - perirenal, donor1	11476-119C9	15.31	0.00	0.00	1.91	0.00	1.28	0.64	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	14.29	0.00	0.00	1.10	0.00	0.00	1.10	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	12.65	3.16	0.90	0.45	0.00	0.00	0.45	0.00	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	18.25	0.17	1.56	0.87	0.35	0.35	0.17	0.00	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	12.91	0.78	0.59	0.59	0.20	0.20	0.20	0.20	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	9.78	0.77	0.51	0.77	0.51	0.26	0.26	0.00	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	8.64	1.12	0.56	0.28	0.00	0.00	0.56	0.00	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	14.70	1.18	0.59	0.59	0.00	0.59	0.00	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	13.19	0.56	0.72	0.48	0.08	0.32	0.24	0.08	0.08
Adipocyte differentiation, day08, donor2	13023-139D8	10.97	0.32	0.32	0.00	0.00	0.32	0.32	0.00	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	9.60	0.00	0.00	0.00	0.00	0.53	0.00	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	13.91	0.00	0.56	0.56	0.00	0.56	1.11	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	7.07	0.42	0.00	0.00	0.00	0.83	0.00	0.42	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	10.80	0.00	0.75	0.00	0.00	0.25	0.75	0.00	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	10.80	0.00	0.00	0.33	0.00	0.33	0.98	0.00	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	8.53	0.30	0.00	0.00	0.30	0.00	0.30	0.61	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	32.93	1.99	0.44	0.88	0.22	0.88	0.66	0.00	0.22
Alveolar Epithelial Cells, donor2	11590-120G6	23.31	0.36	1.43	1.43	0.00	1.08	0.36	0.36	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	9.58	0.00	2.40	3.59	1.20	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	26.99	1.26	2.52	0.36	0.54	0.18	0.18	0.00	0.18
Amniotic Epithelial Cells, donor2	11613-122A2	23.43	0.00	1.67	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	34.72	2.67	1.85	1.85	0.62	0.82	0.41	0.00	0.21
Anulus Pulposus Cell, donor1	11248-116E6	23.23	5.03	1.49	1.37	1.60	1.37	0.46	0.11	0.34
Anulus Pulposus Cell, donor2	11463-119B5	21.80	3.18	1.47	0.98	0.98	0.00	0.49	0.00	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	10.33	0.45	0.90	1.35	0.45	1.35	0.45	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	14.76	0.43	0.00	1.30	0.87	1.30	0.87	0.00	0.87
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	4.28	6.42	0.00	6.42	0.00	6.42	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	13.45	0.90	0.60	1.49	0.30	1.49	0.60	0.00	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	20.23	1.26	1.26	0.00	0.00	1.26	1.26	0.00	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	6.60	2.64	1.32	0.00	0.66	0.00	0.66	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	11.70	1.62	0.97	1.30	0.32	0.97	0.65	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	14.56	1.46	0.49	0.49	0.00	0.97	1.46	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	8.91	1.19	1.19	0.59	0.00	1.19	2.97	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	15.07	0.75	0.00	3.01	0.38	1.51	2.26	0.00	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	13.06	2.90	0.73	2.90	0.00	2.18	0.73	0.00	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	7.52	5.02	0.00	1.25	0.00	1.25	1.25	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	19.44	3.62	0.16	0.33	1.15	0.66	0.49	0.00	0.16
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	8.19	1.36	0.00	0.00	0.00	1.36	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	8.44	0.75	0.00	0.15	0.15	0.00	0.60	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	11.79	0.00	1.07	1.61	0.00	1.07	0.54	0.00	0.54
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	14.55	1.13	0.00	0.94	0.00	1.32	0.38	0.00	0.76
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	17.11	1.07	0.27	1.07	0.00	1.34	0.53	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	9.75	0.98	0.98	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	14.76	2.32	0.00	1.00	0.50	0.66	0.50	0.17	0.17
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	9.61	1.20	0.00	0.00	0.00	2.40	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	10.62	0.00	0.00	3.54	3.54	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	15.09	1.37	0.17	0.86	0.17	1.72	0.17	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	8.39	8.39	0.00	4.19	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	11.16	0.49	0.00	1.94	0.00	2.91	1.94	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	18.97	0.38	0.38	0.76	0.00	1.14	0.76	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	9.69	0.00	1.21	0.00	0.00	3.63	1.21	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	4.56	1.71	0.00	0.57	1.71	1.14	1.14	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	16.25	1.92	0.00	1.28	0.43	1.07	0.43	0.00	0.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	11.36	0.77	0.26	1.03	0.26	1.81	0.52	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	13.61	1.41	0.47	0.94	0.00	0.47	0.94	0.00	0.94
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	18.01	1.29	0.64	1.93	0.32	0.32	0.64	0.00	0.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	8.56	0.00	1.43	0.71	0.00	0.71	1.43	0.00	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	15.21	0.58	0.00	0.58	0.00	0.00	0.58	0.00	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	15.05	1.20	0.00	2.41	0.30	1.81	0.60	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	10.69	3.56	0.00	0.00	0.00	4.75	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	11.70	4.07	0.00	2.54	0.51	2.03	1.02	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	20.88	2.29	0.51	2.55	0.25	0.51	1.02	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	8.26	1.27	0.00	0.64	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	10.79	0.86	0.43	0.43	0.00	2.16	0.86	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	13.34	2.54	0.00	0.42	0.00	1.48	0.85	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	10.15	0.87	1.16	1.16	0.00	0.87	0.29	0.00	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	17.01	1.89	0.94	0.94	0.00	0.94	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	14.92	1.02	0.17	1.36	0.68	1.02	0.00	0.17	0.34
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	4.63	0.00	0.00	0.00	2.32	2.32	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	14.79	0.00	0.00	4.23	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	11.15	1.72	0.21	0.86	0.21	0.21	0.21	0.00	0.43
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	12.63	0.00	0.60	0.00	0.60	1.20	0.60	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	12.39	0.00	0.73	1.46	0.00	1.46	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	17.24	0.46	0.46	1.15	0.92	1.84	0.92	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	12.75	7.65	2.55	2.55	0.00	2.55	2.55	0.00	2.55
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	8.90	1.27	0.25	0.00	0.76	0.00	0.00	0.25	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	19.20	1.24	0.00	1.24	0.21	0.21	1.24	0.41	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	11.63	0.31	0.31	1.22	0.31	0.92	0.92	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	16.73	1.43	0.00	2.87	0.48	1.91	1.43	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	13.30	1.77	0.44	1.77	0.44	1.11	0.00	0.00	0.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	10.68	0.00	0.00	0.00	1.53	1.53	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	12.74	1.11	1.11	0.00	0.00	1.11	1.11	0.00	0.55
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	15.09	2.12	0.00	1.32	0.53	2.12	0.79	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	9.81	1.09	0.73	0.73	0.00	0.00	1.09	0.00	0.73
Astrocyte - cerebellum, donor1	11500-119F6	30.70	0.37	1.11	1.35	0.86	0.74	0.37	0.37	0.86
Astrocyte - cerebellum, donor2	11580-120F5	28.07	0.17	1.37	2.23	0.68	1.37	0.34	0.17	0.51
Astrocyte - cerebellum, donor3	11661-122F5	23.28	0.42	3.36	0.63	1.05	0.63	0.21	0.00	1.26
Astrocyte - cerebral cortex, donor1	11235-116D2	18.82	0.70	0.00	0.70	1.05	0.35	0.00	0.00	1.05
Astrocyte - cerebral cortex, donor2	11316-117D2	23.46	0.49	1.13	1.62	1.29	0.97	0.97	0.00	0.81
Astrocyte - cerebral cortex, donor3	11392-118C6	23.72	0.15	1.49	1.19	1.34	0.30	0.00	0.00	0.75
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	14.11	0.00	1.15	0.92	0.69	0.92	0.11	0.11	0.23
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	20.92	0.00	0.75	1.00	0.63	0.38	0.25	0.13	0.50
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	14.79	0.00	1.02	0.46	1.02	0.23	0.00	0.00	0.11
Basophils, donor1	12241-129G9	8.63	0.00	0.26	0.26	0.00	0.00	0.00	0.00	0.00
Basophils, donor2	12242-129H1	11.91	0.36	1.80	0.00	0.00	0.00	0.36	0.00	0.00
Basophils, donor3	12243-129H2	9.26	0.44	0.15	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	10.78	0.86	0.65	0.22	0.00	0.65	0.00	0.00	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	14.17	0.46	0.46	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	14.35	0.00	7.17	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	13.81	0.00	0.00	0.00	0.00	0.63	0.00	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	16.84	1.04	1.66	0.42	0.62	0.42	0.21	0.00	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	9.67	0.69	1.15	0.46	0.00	0.00	0.00	0.00	0.46
Bronchial Epithelial Cell, donor7	11769-123I5	7.20	1.62	1.98	0.54	0.18	0.72	0.18	0.00	0.18
Burkitt's lymphoma cell line:DAUDI	10422-106C8	10.41	0.10	2.99	0.21	0.93	0.21	0.00	0.00	0.52
Burkitt's lymphoma cell line:RAJI	10476-106I8	13.74	0.00	0.47	0.23	2.10	0.23	0.47	0.00	2.10
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	13.43	0.32	2.24	0.00	0.64	0.00	0.00	0.00	0.64
CD133+ stem cells - cord blood derived, pool1	12223-129E9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	11.27	0.00	0.00	0.00	0.00	0.56	0.00	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	12.06	0.00	0.19	0.19	0.19	0.37	0.00	0.00	0.00
CD14+ Monocytes, donor3	11381-118B4	7.90	0.00	0.00	0.22	0.44	0.22	0.00	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	20.38	0.28	0.85	0.57	0.00	0.00	0.57	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	14.40	0.00	2.65	0.76	0.38	0.00	0.38	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	18.74	0.66	0.66	0.66	0.33	0.00	0.00	0.00	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	8.09	0.14	0.87	0.43	0.00	0.00	0.58	0.00	0.00
CD14+ monocytes - mock treated, donor2	11873-125C1	3.02	0.00	0.60	0.00	0.00	0.00	0.30	0.00	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	8.77	0.00	0.24	0.47	0.00	0.00	0.24	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	4.02	0.00	0.84	0.67	0.00	0.00	0.17	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	4.14	0.00	0.83	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	3.47	0.00	0.25	0.50	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	4.11	0.00	0.39	0.59	0.00	0.39	0.20	0.00	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	2.67	0.00	0.53	0.18	0.18	0.00	0.18	0.00	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	1.74	0.00	0.44	0.44	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	1.17	0.00	0.94	0.47	0.23	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	1.06	0.00	1.58	0.53	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	2.22	0.00	1.11	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	7.88	0.00	0.59	0.30	0.30	0.00	0.30	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	2.79	0.00	0.20	0.20	0.00	0.00	0.20	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	5.41	0.00	0.42	0.00	0.00	0.00	0.21	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	5.26	0.00	0.92	0.00	0.00	0.23	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	2.94	0.00	0.68	0.00	0.00	0.23	0.23	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	3.49	0.00	0.87	0.00	0.00	0.44	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	2.69	0.00	0.00	0.00	0.00	0.27	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	5.41	0.00	0.17	0.00	0.00	0.17	0.17	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	5.47	0.00	0.42	0.00	0.00	0.42	0.42	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	2.76	0.00	0.73	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	0.35	0.00	0.00	0.70	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	3.51	0.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	2.79	0.00	0.35	0.00	0.00	0.17	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	4.09	0.00	0.37	0.00	0.37	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	5.39	0.00	0.43	0.00	0.00	0.22	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	5.32	0.41	0.82	0.41	0.00	0.00	0.41	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	2.78	0.00	0.46	0.23	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	3.25	0.23	0.23	0.00	0.00	0.00	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	9.15	0.00	1.31	0.44	0.00	0.22	0.22	0.00	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	6.70	0.00	0.69	0.00	0.00	0.23	0.46	0.00	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	7.58	0.22	0.65	0.00	0.00	0.00	0.43	0.00	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	12.30	0.00	0.93	0.47	0.00	0.62	0.31	0.00	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	11.70	0.00	2.10	0.35	0.00	0.70	0.35	0.00	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	13.82	0.00	0.67	0.22	0.22	0.22	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	5.10	0.00	0.77	0.00	0.00	0.26	0.26	0.00	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	6.15	0.00	2.20	0.22	0.00	0.22	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	7.16	0.00	1.26	0.21	0.00	0.42	0.42	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	22.36	0.00	2.03	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	8.81	0.00	1.36	0.68	0.00	0.68	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	10.36	0.00	2.07	0.00	0.00	1.04	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	14.93	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	15.55	0.00	1.07	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	7.02	0.00	4.21	0.00	0.00	0.00	0.00	0.00	0.70
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	8.63	0.00	3.14	0.00	0.78	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	10.55	0.00	0.00	0.00	0.00	0.00	1.32	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	9.86	0.00	7.40	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	10.16	0.00	2.90	0.00	0.00	0.00	0.73	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	10.60	0.00	2.02	0.50	0.00	0.50	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	37.98	3.64	1.21	1.21	0.00	0.81	0.81	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	29.96	2.00	1.20	1.20	0.40	0.40	1.20	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	11.04	0.00	0.00	0.00	1.00	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	3.93	0.56	0.56	0.56	0.00	0.00	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	15.78	0.00	0.75	0.38	0.75	0.00	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	15.33	0.68	1.35	0.00	0.90	0.45	0.00	0.00	0.00
CD4+ T Cells, donor1	11225-116C1	12.85	0.36	0.71	1.07	0.36	0.00	0.00	0.00	0.00
CD4+ T Cells, donor2	11306-117C1	8.57	0.00	1.22	1.22	0.00	1.22	1.22	0.00	0.00
CD4+ T Cells, donor3	11382-118B5	12.50	0.30	0.00	0.61	0.30	0.61	0.61	0.00	0.30
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	17.87	0.00	0.77	0.26	0.00	0.77	0.51	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	19.54	0.00	0.67	0.45	0.22	0.67	0.67	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	24.15	0.00	1.44	1.15	0.29	0.29	0.29	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	10.90	0.00	0.47	0.47	0.00	0.47	0.47	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	14.05	0.00	0.70	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	13.18	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	19.51	0.00	0.87	0.43	0.43	0.58	0.72	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	21.86	0.00	1.19	0.68	0.00	1.19	0.85	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	13.54	0.00	0.97	1.13	0.00	0.81	0.32	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	8.52	0.00	0.45	0.45	0.45	0.00	0.45	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	7.69	0.00	0.70	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	13.20	0.00	0.44	1.32	0.44	0.88	0.44	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	20.24	0.00	0.00	0.84	0.42	0.84	0.42	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	13.51	0.00	0.21	0.42	0.21	0.83	1.04	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	13.03	0.00	1.00	0.00	1.00	1.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	14.14	0.00	0.54	0.82	0.00	0.27	0.27	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	7.50	0.00	0.54	0.00	0.54	1.07	0.54	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	17.93	0.00	0.00	1.79	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	18.54	0.00	1.11	0.00	0.37	0.37	0.93	0.00	0.19
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	18.85	0.00	1.30	0.22	0.22	0.65	0.43	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	19.12	0.00	0.84	0.21	0.00	0.84	2.10	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	7.58	0.00	1.01	1.01	0.51	1.52	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	13.43	0.00	0.00	0.43	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	15.25	0.00	0.00	0.87	0.00	0.87	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	19.79	0.00	0.99	0.00	0.00	0.49	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	13.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	16.75	0.00	2.79	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	13.57	0.00	1.66	0.55	0.00	0.00	0.00	0.00	0.28
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	14.97	0.00	0.25	0.74	0.49	0.49	0.25	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	29.26	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	21.13	0.00	1.79	0.72	0.36	0.72	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	24.93	0.00	2.77	0.00	0.00	1.38	1.38	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	15.39	0.00	0.33	0.33	0.65	0.65	0.00	0.00	0.00
CD8+ T Cells, donor2	11307-117C2	13.52	0.38	0.75	1.13	0.38	1.50	0.38	0.00	0.00
CD8+ T Cells, donor3	11383-118B6	13.63	0.50	0.00	0.50	0.76	0.25	0.50	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	5.28	0.00	0.23	0.23	0.23	0.23	0.92	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	5.51	0.00	0.72	0.24	0.48	0.96	0.24	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	5.47	0.55	0.00	0.82	1.64	0.82	0.55	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	4.20	0.60	0.60	0.60	1.50	0.60	0.60	0.00	0.60
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	8.16	0.24	0.24	0.24	1.44	0.00	0.24	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	5.00	0.23	0.00	0.00	0.00	0.23	0.68	0.00	0.45
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	5.00	0.00	0.00	0.65	0.65	0.22	0.65	0.00	0.43
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	7.37	0.53	0.00	0.26	0.79	0.79	0.26	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	4.22	0.47	0.23	1.17	0.70	1.17	0.00	0.00	0.23
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	8.45	0.60	0.60	1.21	1.21	0.60	0.60	0.00	0.60
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	8.42	0.58	0.87	0.29	2.03	0.87	1.45	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	9.33	0.27	0.27	0.80	0.80	1.07	0.27	0.00	0.53
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	3.50	1.31	0.00	0.44	0.88	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	5.47	1.82	0.00	0.00	0.00	0.91	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	5.22	5.97	0.00	0.00	0.75	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	4.68	0.00	0.36	0.36	1.08	0.36	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	4.89	0.29	0.29	0.29	1.15	0.29	0.86	0.29	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	7.07	0.24	0.47	0.71	0.71	0.24	0.24	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	7.92	0.00	0.00	0.63	1.27	0.00	0.32	0.00	0.32
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	7.07	0.00	0.31	0.62	0.92	1.23	0.00	0.00	0.31
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	8.01	0.96	0.00	0.96	0.00	0.64	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	5.35	0.00	0.76	0.38	0.00	0.00	0.00	0.00	0.38
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	7.88	0.00	0.79	0.79	1.18	0.79	1.18	0.00	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	3.03	0.00	0.00	0.76	0.00	0.76	0.76	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	9.64	0.00	0.00	0.80	0.80	0.00	0.00	0.00	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	8.39	4.20	0.00	1.40	1.40	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	4.01	3.01	0.00	2.00	0.00	0.00	0.00	0.00	3.01
Cardiac Myocyte, donor1	11525-119I4	27.42	7.31	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	26.19	0.49	0.00	2.47	0.00	1.48	0.49	0.00	0.49
Cardiac Myocyte, donor3	11686-122I3	15.68	0.74	0.53	0.21	0.21	0.32	0.21	0.21	0.00
Chondrocyte - de diff, donor1	11261-116G1	5.89	0.00	0.69	2.08	0.00	0.69	0.35	0.00	0.00
Chondrocyte - de diff, donor2	11338-117F6	17.06	2.49	1.07	0.36	1.42	0.36	0.00	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	13.65	1.93	1.14	1.59	0.46	1.82	0.57	0.00	0.00
Chondrocyte - re diff, donor2	11339-117F7	13.43	1.79	0.00	0.90	1.79	0.00	0.00	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	18.60	0.81	1.62	0.40	2.02	0.40	0.81	0.00	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	19.28	1.15	2.75	0.80	2.18	0.80	0.23	0.23	0.69
Ciliary Epithelial Cells, donor2	11323-117D9	20.74	0.00	0.64	2.14	1.71	1.71	0.64	0.00	0.00
Ciliary Epithelial Cells, donor3	11399-118D4	18.14	0.88	0.62	1.33	0.88	0.97	0.35	0.09	0.53
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	28.98	2.20	1.65	2.11	0.73	0.73	0.64	7.24	0.09
Corneal Epithelial Cells, donor1	11526-119I5	15.81	3.07	2.85	0.66	0.22	0.00	0.22	0.00	0.66
Corneal Epithelial Cells, donor2	11606-120I4	15.93	1.14	2.28	1.14	0.00	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	14.32	3.07	4.09	0.26	0.26	0.77	0.00	0.00	0.51
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	16.67	0.00	1.49	0.50	0.17	0.17	0.17	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	14.82	0.00	0.63	0.32	0.00	0.32	0.32	0.00	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	17.25	0.00	0.00	0.00	3.45	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	15.44	0.00	0.32	0.43	0.11	0.86	0.32	0.00	0.11
Dendritic Cells - plasmacytoid, donor1	11228-116C4	18.45	0.00	0.00	0.00	0.34	0.34	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	13.06	0.00	1.31	0.00	1.31	0.00	0.65	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	15.97	0.00	0.48	0.00	0.48	0.48	0.00	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	9.67	0.33	0.50	0.00	0.00	0.17	0.00	0.17	0.33
Endothelial Cells - Aortic, donor1	11263-116G3	8.80	0.00	0.00	0.00	0.00	1.17	0.00	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	14.14	0.00	0.28	0.00	0.28	0.28	0.00	0.00	0.28
Endothelial Cells - Aortic, donor3	11412-118E8	7.86	0.00	0.39	0.00	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	11.05	0.00	0.58	0.29	0.00	0.00	0.58	0.00	0.87
Endothelial Cells - Artery, donor2	11341-117F9	14.82	0.00	0.24	0.47	0.24	0.94	0.47	0.00	0.00
Endothelial Cells - Artery, donor3	11413-118E9	16.13	0.00	0.00	0.18	0.18	0.53	0.00	0.00	0.53
Endothelial Cells - Lymphatic, donor1	11236-116D3	10.64	0.22	1.11	0.22	1.77	0.44	0.00	0.00	0.44
Endothelial Cells - Lymphatic, donor2	11317-117D3	9.74	0.30	0.61	0.30	0.61	0.30	0.00	0.00	0.61
Endothelial Cells - Lymphatic, donor3	11393-118C7	18.32	0.28	1.41	0.00	0.56	0.56	0.00	0.00	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	3.27	0.00	0.59	0.30	0.59	0.00	0.30	0.00	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	10.41	0.52	3.12	0.52	0.00	0.52	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	8.93	0.14	0.99	0.57	0.43	0.28	0.43	0.28	0.14
Endothelial Cells - Thoracic, donor1	11266-116G6	6.40	0.00	0.00	0.40	0.40	1.20	0.40	0.40	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	11.53	0.00	0.00	0.52	0.52	0.52	0.52	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	14.41	0.12	0.50	0.50	0.75	0.99	0.37	0.00	0.62
Endothelial Cells - Umbilical vein, donor2	11324-117E1	10.65	0.22	0.65	0.00	0.22	0.00	0.22	0.22	0.22
Endothelial Cells - Umbilical vein, donor3	11400-118D5	13.19	0.24	0.73	0.37	0.12	0.37	0.12	0.00	0.37
Endothelial Cells - Vein, donor1	11267-116G7	14.79	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	22.35	0.00	0.00	0.00	0.70	0.00	0.00	0.00	0.70
Endothelial Cells - Vein, donor3	11416-118F3	12.87	0.00	0.00	0.16	0.31	0.47	0.31	0.00	0.16
Eosinophils, donor1	12244-129H3	0.00	15.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	16.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	14.27	0.00	3.57	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	15.88	1.95	0.24	0.24	0.24	0.24	0.24	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	12.48	0.00	4.16	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	48.81	0.00	0.00	0.00	0.00	16.27	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	10.26	4.11	0.00	0.41	0.00	0.41	0.41	0.00	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	7.12	1.20	0.33	2.63	0.00	1.31	1.53	0.00	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	10.08	0.54	0.54	4.23	0.22	2.49	3.79	0.11	0.00
Fibroblast - Aortic Adventitial, donor1	11245-116E3	17.95	1.82	0.49	0.61	0.49	0.61	0.61	0.00	0.24
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	6.41	3.00	0.41	0.00	0.41	0.14	0.41	0.27	0.27
Fibroblast - Aortic Adventitial, donor2	11326-117E3	18.14	1.69	0.74	1.48	0.11	0.84	1.69	0.00	0.32
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	10.80	1.32	0.00	1.58	0.53	0.53	0.79	0.00	0.79
Fibroblast - Aortic Adventitial, donor3	11401-118D6	19.93	0.00	0.66	1.33	0.33	1.33	1.00	0.00	0.00
Fibroblast - Cardiac, donor1	11268-116G8	16.78	2.72	0.00	0.00	0.00	0.00	0.45	0.00	0.45
Fibroblast - Cardiac, donor2	11345-117G4	21.22	2.27	0.00	0.00	0.00	0.76	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	12.62	1.10	0.32	0.95	0.47	0.63	0.47	0.00	0.00
Fibroblast - Cardiac, donor4	11452-119A3	14.55	1.82	0.91	0.00	0.61	0.00	0.30	0.00	0.00
Fibroblast - Cardiac, donor5	11456-119A7	12.82	0.38	0.76	0.25	0.13	0.38	0.63	0.00	0.38
Fibroblast - Cardiac, donor6	11460-119B2	12.73	0.76	0.00	0.76	0.30	0.76	0.45	0.00	0.76
Fibroblast - Choroid Plexus, donor1	11492-119E7	27.60	0.94	2.55	0.40	0.13	0.13	0.40	0.27	1.07
Fibroblast - Choroid Plexus, donor2	11572-120E6	15.96	1.29	2.59	0.43	0.00	0.43	1.29	0.00	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	19.04	1.46	5.86	1.46	1.46	0.00	0.00	0.00	1.46
Fibroblast - Conjunctival, donor1	11531-120A1	32.75	2.08	0.92	0.46	1.15	0.00	0.00	0.00	0.69
Fibroblast - Conjunctival, donor3	11692-122I9	24.42	1.02	2.04	1.02	1.87	0.34	0.85	0.00	0.34
Fibroblast - Dermal, donor1	11269-116G9	16.67	0.70	0.23	0.23	0.47	1.17	1.17	0.00	0.00
Fibroblast - Dermal, donor2	11346-117G5	16.04	0.47	0.94	0.94	0.47	0.00	0.00	0.47	0.00
Fibroblast - Dermal, donor3	11418-118F5	13.66	0.85	0.48	0.85	0.00	0.60	1.45	0.24	0.00
Fibroblast - Dermal, donor4	11450-119A1	15.60	0.23	0.90	1.02	0.34	0.79	0.11	0.11	0.00
Fibroblast - Dermal, donor5	11454-119A5	20.24	0.00	0.52	1.05	0.17	0.52	0.35	0.00	0.17
Fibroblast - Dermal, donor6	11458-119A9	19.49	0.32	1.14	1.14	0.49	1.30	0.16	0.00	0.16
Fibroblast - Gingival, donor1	11237-116D4	19.37	2.92	0.62	0.83	1.04	0.42	0.00	0.00	0.62
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	21.22	2.62	0.26	1.31	0.00	1.05	1.83	0.26	0.00
Fibroblast - Gingival, donor2	11318-117D4	22.80	1.05	2.24	2.11	0.79	1.58	2.11	0.13	0.13
Fibroblast - Gingival, donor3	11394-118C8	20.59	3.00	0.97	1.06	0.48	0.39	0.39	0.19	0.39
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	11.43	1.04	2.08	0.00	0.00	0.00	1.04	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	16.56	1.41	0.00	2.11	0.18	0.53	1.41	0.00	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	20.11	0.94	0.94	0.78	0.62	1.25	0.94	0.00	0.31
Fibroblast - Gingival, donor6 (control)	11922-125H5	18.80	0.41	0.81	1.76	0.41	1.35	1.08	0.00	0.14
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	43.76	0.71	1.06	2.82	1.06	0.71	2.47	0.00	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	21.94	0.29	1.02	0.73	0.44	0.73	0.58	0.00	0.00
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	14.45	0.95	0.68	1.77	0.68	0.68	0.55	0.00	0.14
Fibroblast - Gingival, donor8 (control)	11926-125H9	20.95	0.11	0.11	0.99	0.99	0.88	1.21	0.00	0.00
Fibroblast - Gingival, donor9 (control)	11927-125I1	16.73	1.47	1.32	1.03	0.59	1.03	1.91	0.00	0.15
Fibroblast - Lung, donor1	11270-116H1	24.47	1.36	0.00	0.00	0.00	1.36	1.36	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	25.37	4.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	13.93	2.95	0.00	1.06	1.06	2.32	0.84	0.00	0.21
Fibroblast - Lymphatic, donor1	11506-119G3	58.31	0.83	2.50	0.83	0.00	0.83	0.83	0.00	0.83
Fibroblast - Lymphatic, donor2	11586-120G2	30.77	0.00	1.40	2.80	0.00	0.00	0.00	0.00	1.40
Fibroblast - Lymphatic, donor3	11667-122G2	31.07	0.84	1.40	0.84	0.00	0.84	0.56	0.00	0.28
Fibroblast - Mammary, donor1	11540-120B1	39.78	0.81	1.22	0.41	0.41	0.00	0.00	0.00	0.41
Fibroblast - Mammary, donor2	11620-122A9	23.97	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	35.74	5.96	0.00	0.00	0.00	0.00	0.00	0.00	5.96
Fibroblast - Periodontal Ligament, donor1	11238-116D5	23.47	1.16	0.97	0.97	0.97	0.19	0.39	0.00	0.19
Fibroblast - Periodontal Ligament, donor2	11319-117D5	32.46	0.91	1.97	1.97	1.06	0.91	0.61	0.00	0.15
Fibroblast - Periodontal Ligament, donor3	11395-118C9	33.35	0.92	1.22	0.61	0.31	0.00	0.31	0.00	0.31
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	16.41	0.00	0.76	0.76	0.00	0.00	0.38	0.00	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	21.33	0.54	1.35	0.81	0.00	1.89	0.54	0.00	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	16.47	0.81	0.23	0.58	0.35	0.58	0.70	0.00	0.00
Fibroblast - Pulmonary Artery, donor1	11250-116E8	13.37	0.77	0.44	1.11	0.33	0.44	0.22	0.00	0.11
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	39.62	1.42	0.81	0.00	0.61	0.41	0.20	0.20	0.41
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	24.72	2.00	4.68	0.67	2.00	0.00	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	17.40	1.58	0.79	0.00	0.79	0.40	0.00	0.79	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	13.49	0.40	0.40	0.99	0.40	0.20	0.40	0.20	0.40
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	15.81	0.53	1.60	1.42	0.00	0.36	0.36	0.00	0.18
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	16.36	1.38	0.59	0.79	0.20	0.39	0.79	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	15.04	0.60	0.90	0.60	0.90	0.60	0.00	0.00	0.90
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	16.73	1.08	1.84	1.51	0.11	1.40	0.32	0.00	0.22
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	9.87	0.51	0.25	0.25	0.00	0.51	0.00	0.25	0.51
Fibroblast - skin normal, donor1	11553-120C5	19.36	0.49	0.16	0.66	0.33	0.49	0.49	0.00	0.33
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	12.03	1.00	1.00	0.40	1.00	0.00	0.40	0.00	0.00
Fibroblast - skin normal, donor2	11561-120D4	18.08	1.21	1.21	1.00	0.10	1.31	1.21	0.00	0.70
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	11.79	1.51	0.60	1.51	0.91	0.00	0.60	0.00	0.60
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	16.15	0.91	1.66	0.50	0.41	0.41	0.66	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	14.53	2.74	1.37	2.05	0.34	1.88	1.03	0.00	0.17
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	14.45	0.00	0.33	0.99	0.33	1.31	0.00	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	21.52	0.75	0.75	2.02	0.75	0.64	0.75	0.00	0.11
Fibroblast - skin walker warburg, donor1	11554-120C6	17.37	1.01	0.67	0.84	0.51	0.84	0.34	0.00	0.17
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	14.11	1.57	0.47	5.02	0.47	3.92	4.08	0.00	0.31
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	0.00	0.00	22.16	0.00	0.00	0.00	66.48	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	7.84	0.00	0.87	0.87	0.00	0.00	0.00	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	9.53	1.73	0.52	0.00	0.17	0.35	0.69	0.00	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	14.57	0.78	0.26	0.26	0.00	0.00	0.26	0.00	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	15.33	3.32	0.00	0.00	0.00	0.00	0.77	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	16.84	1.53	0.00	0.00	2.30	1.53	4.59	1.53	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	8.29	2.55	1.91	2.55	3.19	1.28	2.55	0.64	1.28
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	19.11	6.28	3.14	2.00	4.56	0.86	7.13	0.00	2.57
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	51.84	3.86	0.55	6.89	4.69	1.10	17.10	0.55	6.34
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	28.31	2.51	0.91	1.83	3.88	0.91	6.62	0.46	3.42
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	27.94	2.58	1.19	4.16	2.77	1.59	6.34	0.00	2.97
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	46.26	4.23	0.26	5.29	4.23	2.64	18.24	0.26	4.49
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	25.44	1.96	0.65	3.26	3.59	1.30	4.24	0.65	1.96
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	19.02	5.75	2.21	4.42	4.86	0.88	8.40	0.00	2.65
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	20.07	4.10	2.54	1.84	2.83	1.55	1.27	1.84	4.10
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	23.03	3.32	2.22	1.48	2.59	1.60	0.74	0.99	4.43
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	16.12	4.57	2.69	2.15	3.76	1.61	1.34	0.81	3.49
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	18.96	0.74	0.74	1.36	1.98	1.24	0.74	0.87	3.47
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	18.27	2.08	0.97	1.11	1.52	1.25	0.97	0.00	3.32
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	16.47	2.64	1.22	1.83	2.85	1.83	1.02	1.22	2.24
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	21.22	1.60	2.28	1.14	2.97	0.68	2.28	1.14	1.60
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	16.32	1.62	0.87	1.12	2.37	0.75	0.12	0.37	2.37
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	20.11	1.09	2.40	0.87	1.53	0.00	0.44	1.09	1.31
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	28.07	1.18	1.77	2.66	2.95	2.36	1.48	0.89	4.14
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	20.19	1.91	1.91	1.43	2.70	2.54	0.79	0.32	2.86
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	27.93	2.68	1.79	1.12	1.79	0.89	0.22	2.01	1.79
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	29.64	0.60	1.41	4.23	3.43	3.23	1.21	0.40	2.42
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	21.04	1.70	2.04	1.70	3.39	1.87	1.87	0.17	2.37
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	27.40	2.84	1.42	1.77	2.22	0.80	1.95	1.15	2.22
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	30.70	0.62	4.58	1.25	6.87	0.00	3.12	0.83	3.75
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	32.45	0.51	4.61	0.51	2.90	0.51	3.59	1.02	1.71
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	26.67	1.33	1.77	1.55	2.55	1.22	1.11	0.33	2.99
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	25.87	2.58	2.25	1.50	2.66	0.58	0.75	2.00	3.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	20.83	1.63	1.43	0.82	2.65	0.00	0.41	0.82	2.65
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	28.47	1.65	1.24	1.86	3.09	1.65	2.06	1.03	3.30
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	25.60	1.61	1.50	1.96	3.34	0.92	0.92	0.00	3.23
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	30.18	1.17	1.67	0.67	2.50	0.83	1.17	0.67	1.83
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	25.79	0.66	2.65	1.10	3.31	1.10	1.54	0.00	2.87
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	24.97	2.21	2.58	1.72	3.20	1.23	1.97	0.00	2.46
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	24.31	2.11	1.30	1.30	2.92	1.95	1.30	0.81	3.73
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	29.19	0.96	5.45	1.92	4.17	0.96	2.57	0.64	2.25
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	23.12	0.85	1.23	1.61	2.37	0.85	1.61	0.09	1.99
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	26.26	1.11	1.58	0.47	2.06	1.58	1.27	0.32	2.06
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	32.54	1.52	1.52	1.82	2.74	1.22	3.34	0.61	1.22
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	23.21	1.25	1.78	1.78	2.20	1.36	1.15	0.21	2.61
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	29.86	0.88	1.54	1.54	1.54	1.32	1.32	1.10	1.54
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	30.02	1.12	1.68	1.68	1.96	1.40	1.12	1.12	1.96
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	26.20	0.74	0.83	0.74	1.11	0.46	1.30	0.37	1.48
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	30.48	1.07	0.27	1.60	2.67	2.14	1.60	0.00	0.80
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	30.60	0.61	0.77	1.07	1.22	1.22	1.68	0.15	0.46
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	26.56	0.26	1.30	2.33	1.04	1.04	1.30	0.39	0.52
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	31.99	1.08	1.90	3.25	1.08	0.27	1.08	0.54	1.36
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	28.02	1.84	1.66	2.58	2.03	2.03	2.03	0.00	1.29
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	21.93	0.66	1.75	1.75	0.88	1.97	2.41	0.00	1.54
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	54.55	0.00	10.91	3.97	3.97	0.99	0.99	0.00	3.97
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	25.46	0.26	1.06	0.40	1.06	0.79	1.32	0.00	0.66
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	28.65	1.21	1.21	1.21	0.81	1.01	1.61	0.00	0.61
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	72.69	5.34	17.03	5.08	12.45	0.25	1.78	2.80	8.64
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	15.92	4.98	6.77	1.19	2.79	1.99	1.79	0.40	11.55
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	17.56	5.55	3.39	2.00	3.39	1.54	1.39	0.15	4.31
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	19.84	9.62	3.07	1.43	4.50	2.05	1.02	0.00	5.93
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	10.64	1.88	1.25	0.31	4.69	0.63	0.63	0.94	3.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	9.04	2.54	1.70	0.28	3.39	0.85	1.98	0.00	5.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	10.15	3.23	1.38	1.38	3.23	1.84	0.46	0.46	4.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	12.37	4.95	0.00	2.47	0.00	0.00	7.42	0.00	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	16.25	6.58	0.00	2.32	3.87	0.77	1.93	0.77	4.64
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	16.04	0.00	0.00	4.81	4.81	4.81	3.21	1.60	11.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	5.22	1.74	1.74	0.00	3.48	0.00	0.00	0.00	6.96
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	15.30	3.25	0.33	2.60	1.95	1.95	1.30	1.95	3.25
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	16.47	3.71	0.82	2.88	2.47	2.06	0.82	1.65	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	16.66	0.00	0.00	10.00	3.33	3.33	3.33	3.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	14.54	3.08	0.56	3.64	2.80	0.84	1.96	3.64	4.75
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	11.44	3.92	0.33	3.92	2.29	1.31	2.29	4.58	1.96
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	10.90	4.19	0.84	0.00	4.19	0.84	0.84	0.84	10.07
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	14.95	2.86	0.64	1.27	4.77	2.23	1.59	2.86	4.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	18.68	3.74	1.02	4.08	3.06	1.70	2.72	3.40	2.04
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	14.62	4.18	2.09	0.00	2.09	0.00	4.18	0.00	2.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	22.34	1.72	0.57	5.15	3.44	5.15	4.01	2.29	5.73
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	10.66	1.48	1.18	3.26	3.26	2.96	2.66	3.85	2.96
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	11.86	6.78	0.00	1.69	5.08	5.08	1.69	5.08	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	18.64	5.80	0.83	3.31	2.49	1.24	4.14	5.38	4.14
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	20.02	3.91	1.15	2.76	1.84	1.38	2.99	3.91	4.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	15.81	10.54	0.00	0.00	0.00	0.00	5.27	5.27	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	14.61	4.61	0.77	4.23	2.31	2.31	0.77	5.00	1.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	9.45	1.63	0.98	1.30	1.96	0.65	2.28	1.63	2.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	8.69	1.34	2.01	2.68	3.34	0.67	3.34	5.35	2.01
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	21.19	4.24	0.77	3.47	3.08	3.47	4.24	2.70	2.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	17.12	3.08	0.34	2.05	3.77	1.03	2.40	6.16	1.71
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	12.42	2.48	0.00	4.97	2.48	0.00	2.48	0.00	2.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	11.80	1.42	0.94	2.83	3.30	1.42	3.30	1.89	3.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	16.29	1.81	1.21	1.81	6.64	1.21	0.00	1.21	1.81
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	15.26	3.05	0.51	0.51	2.54	0.51	2.03	2.54	4.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	13.56	3.19	0.80	2.79	4.79	1.99	0.40	2.79	6.78
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	14.80	4.44	0.99	0.49	2.96	1.48	1.48	2.96	3.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	20.07	2.36	0.00	2.36	7.08	2.36	3.54	0.00	3.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	13.42	2.33	2.33	1.75	4.08	0.00	0.58	1.75	2.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	13.61	1.32	0.88	0.88	5.27	2.63	0.44	2.63	2.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	5.93	0.00	0.00	0.85	1.70	0.85	3.39	0.85	3.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	16.12	3.58	0.60	2.39	1.19	2.39	3.58	4.18	1.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	13.59	1.94	0.97	3.88	0.97	1.46	1.46	2.91	1.46
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	12.55	1.14	0.00	0.00	0.00	0.00	2.28	0.00	3.42
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	15.39	0.42	0.83	2.91	0.42	2.08	0.83	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	41.60	0.00	0.00	3.37	0.00	1.12	2.25	0.00	1.12
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	19.66	0.63	3.81	1.27	0.63	1.59	0.95	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	22.56	0.84	1.25	1.25	1.25	0.00	1.25	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	21.70	0.35	0.46	2.09	0.70	1.51	0.46	0.12	0.12
Hep-2 cells mock treated, biol_rep2	11899-125E9	21.44	1.69	0.51	1.35	0.51	0.51	0.51	0.17	0.17
Hep-2 cells mock treated, biol_rep3	11900-125F1	17.52	0.68	0.68	1.37	0.00	0.68	0.23	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	18.69	1.20	0.66	1.31	0.22	0.87	1.09	0.00	0.11
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	18.27	1.72	0.86	1.07	0.43	0.64	0.64	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	17.01	0.65	0.00	0.65	0.00	1.29	0.43	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	20.30	1.87	0.25	1.25	0.62	1.62	0.12	0.12	0.12
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	19.56	2.23	0.17	0.69	0.34	0.86	0.86	0.00	0.17
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	10.89	1.60	0.64	2.24	0.32	0.32	0.00	0.32	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	10.63	0.00	0.00	1.68	0.00	0.56	0.56	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	19.04	0.43	0.87	0.43	0.00	1.73	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	10.58	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	26.45	2.47	0.35	0.71	0.71	0.00	0.35	0.00	0.71
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	24.70	1.45	0.73	0.00	0.73	0.73	0.73	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	16.78	1.40	0.17	0.70	0.35	0.52	0.70	0.17	0.17
Hepatocyte, donor1	11523-119I2	9.68	0.00	0.00	2.42	0.00	3.63	1.21	21.79	0.00
Hepatocyte, donor2	11603-120I1	9.70	0.00	0.00	2.15	0.00	0.00	2.15	4.31	0.00
Hepatocyte, donor3	11684-122I1	8.59	2.45	0.00	1.23	0.00	0.00	0.61	7.36	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	21.54	0.00	0.00	0.65	2.61	0.65	1.31	0.00	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	14.16	8.91	2.62	2.27	1.40	0.35	0.00	12.06	1.05
Iris Pigment Epithelial Cells, donor1	11530-119I9	17.01	1.51	0.27	1.23	0.69	0.41	0.41	0.00	0.27
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	50.94	0.00	0.00	0.00	3.18	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	66.75	0.00	0.00	0.00	0.00	0.00	6.68	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	34.61	2.77	4.15	2.77	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	50.05	2.50	0.00	0.00	0.00	2.50	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	23.74	0.00	0.00	0.00	0.00	0.00	11.87	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	84.58	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	68.56	0.00	0.00	0.00	0.00	4.57	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	58.48	1.62	1.62	0.00	3.25	3.25	1.62	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	46.68	3.33	3.33	0.00	0.00	1.67	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	14.52	0.00	3.63	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	51.62	2.65	2.65	2.65	0.00	2.65	3.97	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	38.80	1.11	1.11	2.22	1.11	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	26.19	0.00	5.24	10.48	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	36.53	1.89	1.26	1.26	0.00	2.52	1.26	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	38.67	0.00	4.64	1.55	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	60.73	0.00	2.58	1.94	0.65	3.88	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	54.74	0.00	6.44	0.00	0.00	3.22	1.61	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	23.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	43.19	0.00	2.44	1.63	0.00	7.33	0.81	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	50.38	0.84	1.68	1.26	1.26	2.10	0.84	0.42	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	14.37	0.00	14.37	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	54.65	0.80	2.41	2.41	0.00	0.00	0.80	0.80	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	46.16	1.85	0.92	0.92	0.00	0.92	0.92	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	33.99	0.94	0.94	0.47	0.94	4.25	0.47	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	39.00	0.91	3.63	0.91	0.91	2.72	2.72	0.91	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	14.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	43.04	0.00	2.15	3.23	0.00	2.15	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	41.93	2.54	3.81	3.81	0.00	3.81	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	49.29	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	39.54	0.64	3.83	1.91	0.00	2.55	1.28	0.00	0.64
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	56.50	0.00	0.00	3.65	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	50.70	1.43	1.43	2.86	0.00	3.57	0.71	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	49.77	3.32	3.32	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	38.89	1.54	1.23	3.09	0.31	1.85	0.31	0.62	0.31
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	40.39	0.00	0.00	1.76	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	50.29	0.00	3.14	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	43.11	0.00	0.00	0.70	0.70	3.48	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	68.61	0.00	0.00	4.43	2.21	2.21	2.21	2.21	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	55.11	0.00	3.24	3.24	0.00	6.48	3.24	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	63.65	0.00	3.49	4.36	0.00	0.87	2.62	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	53.99	0.00	2.25	2.25	0.00	2.25	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	45.30	0.00	3.48	0.00	0.00	3.48	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	56.54	2.13	3.20	1.07	0.00	2.13	2.13	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	38.79	0.00	2.77	2.77	1.39	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	37.04	0.00	2.85	2.85	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	44.18	0.92	1.84	1.84	0.00	2.76	0.92	0.92	0.92
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	54.46	3.03	3.03	3.03	0.00	0.00	3.03	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	31.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	40.18	0.00	4.23	1.06	0.00	2.11	0.00	0.00	1.06
Keratinocyte - epidermal, donor1	11272-116H3	14.12	3.67	0.90	1.63	0.16	0.49	0.82	0.08	0.24
Keratinocyte - epidermal, donor2	11349-117G8	8.78	1.17	0.59	0.00	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	12.78	1.99	0.28	0.85	0.47	0.19	0.19	0.00	0.00
Keratinocyte - oral, donor1	11251-116E9	19.87	5.11	4.20	0.91	0.79	0.79	0.57	0.00	0.34
Keratocytes, donor1	11527-119I6	25.79	1.38	0.00	0.00	0.34	0.34	0.34	0.00	0.69
Keratocytes, donor2	11607-120I5	22.26	3.52	3.52	1.17	0.00	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	13.24	1.19	1.19	0.40	0.59	0.59	0.20	0.00	0.79
Krukenberg tumor cell line:HSKTC	10687-109F3	6.59	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	14.02	0.00	0.00	3.24	0.00	3.24	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	29.87	0.81	1.73	1.27	1.04	0.46	0.46	0.00	0.69
Lens Epithelial Cells, donor3	11690-122I7	28.96	1.61	0.40	0.40	1.01	0.00	0.40	0.00	0.61
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	13.99	0.12	0.59	1.07	0.59	0.36	0.24	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	11.44	0.00	1.40	0.84	0.00	0.28	0.28	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	7.71	0.16	0.79	1.10	0.47	1.10	0.63	0.16	0.63
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	7.53	0.00	0.00	0.00	1.08	0.00	1.08	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	12.61	0.00	2.21	1.26	0.32	0.00	0.32	0.00	0.63
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	11.21	0.00	1.62	1.19	0.75	0.32	0.65	0.22	0.22
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	11.08	0.00	0.41	0.00	0.00	0.41	0.00	0.41	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	11.38	0.25	1.77	0.25	0.76	0.00	0.00	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	8.30	0.14	1.13	0.99	0.42	0.99	0.14	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	7.91	0.00	0.00	0.79	0.40	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	8.53	0.00	0.97	0.19	0.58	0.19	0.19	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	9.26	0.00	0.93	0.19	0.37	0.37	0.56	0.00	0.19
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	10.45	0.00	0.35	0.70	0.70	0.70	0.00	0.00	0.70
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	10.97	0.24	0.72	0.24	0.72	0.00	0.24	0.00	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	10.71	0.14	1.10	0.69	0.41	0.41	0.27	0.14	0.14
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	11.39	0.00	0.31	0.62	1.23	0.00	0.00	0.62	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	8.42	0.00	2.18	0.31	0.31	0.62	0.62	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	12.26	0.37	0.91	0.91	0.37	0.37	0.55	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	7.57	0.33	0.00	0.33	0.33	0.00	0.33	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	8.20	0.00	1.17	0.00	0.29	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	10.70	0.00	0.75	0.50	1.00	0.50	0.25	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	4.36	0.00	0.48	0.97	0.00	0.48	0.00	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	6.46	0.00	0.54	0.54	0.54	0.00	0.27	0.27	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	8.93	0.15	1.21	0.76	0.15	0.45	0.15	0.00	0.15
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	6.74	0.00	1.04	0.52	0.52	1.04	0.52	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	10.05	0.00	1.05	0.21	0.42	0.42	0.00	0.00	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	9.17	0.00	0.90	0.60	0.15	0.15	0.00	0.15	0.15
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	5.50	0.00	0.00	0.00	0.69	0.69	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	5.46	0.00	0.56	0.56	0.56	0.38	0.94	0.19	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	9.22	0.42	1.70	0.95	1.06	0.32	0.21	0.11	0.32
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	7.27	0.48	0.48	0.00	0.00	0.48	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	5.29	0.00	1.65	0.66	0.99	0.00	0.33	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	9.91	0.25	0.62	0.62	0.37	0.00	0.37	0.00	0.12
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	12.96	0.00	0.74	0.00	1.11	0.74	0.74	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	7.91	0.49	1.98	0.25	0.74	0.00	0.25	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	9.90	0.00	0.82	0.55	0.41	0.41	0.27	0.27	0.41
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	11.26	0.00	0.64	0.96	0.00	0.64	0.32	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	8.22	0.00	0.61	0.91	0.00	0.30	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	9.10	0.14	1.12	0.98	0.42	0.14	0.28	0.14	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	7.11	0.00	0.00	0.71	0.36	0.36	0.36	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	7.76	0.00	1.45	0.00	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	11.20	0.00	1.71	0.78	0.00	0.31	0.62	0.00	0.16
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	6.09	0.00	0.36	0.72	0.00	0.72	0.36	0.00	0.36
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	7.51	0.00	1.63	0.00	1.31	0.00	0.00	0.33	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	8.24	0.00	0.94	0.71	0.47	0.24	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	14.36	0.37	0.50	0.50	0.25	0.00	0.87	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	7.17	0.00	0.51	0.00	0.51	0.51	0.26	0.26	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	7.46	0.00	0.90	0.60	0.60	0.30	0.30	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	4.53	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	10.74	0.77	3.07	0.77	0.00	0.77	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	4.45	0.74	2.23	0.00	0.00	0.74	1.48	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	12.69	0.00	6.35	0.00	0.00	1.69	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	9.14	0.70	6.33	1.41	0.00	0.70	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	6.54	0.00	2.80	0.93	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	7.73	0.52	4.12	1.55	0.52	2.58	0.52	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	10.71	0.00	3.57	1.19	0.00	0.00	1.19	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	6.56	0.45	4.98	0.90	0.45	0.90	0.23	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	4.94	0.29	4.94	1.16	0.29	0.00	1.16	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	9.90	0.00	3.60	0.45	0.45	0.45	0.45	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	10.84	0.27	4.88	0.54	0.41	0.54	0.81	0.00	0.14
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	6.68	0.51	4.11	1.03	0.51	1.03	0.51	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	9.17	0.00	3.18	0.00	0.00	0.00	1.06	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	9.33	0.00	3.33	1.33	0.00	0.67	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	8.66	0.00	2.55	0.00	0.00	1.02	1.02	0.00	0.51
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	10.94	0.53	3.20	0.27	0.00	0.27	0.27	0.00	0.27
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	7.56	0.19	3.78	1.32	0.00	0.38	0.19	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	9.20	1.23	3.68	1.84	0.61	0.61	1.84	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	13.05	0.00	8.97	0.82	0.00	0.82	0.00	0.00	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	7.91	0.00	3.96	1.87	0.62	0.42	0.00	0.00	0.21
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	6.17	0.00	3.08	1.40	0.28	1.12	0.84	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	11.33	0.00	6.18	1.03	1.03	1.03	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	7.55	0.00	4.06	1.74	0.29	0.87	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	6.58	0.00	2.69	0.60	0.00	0.90	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	6.09	0.00	3.87	0.55	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	12.02	0.35	5.30	1.06	0.00	1.41	0.71	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	4.79	0.37	4.79	0.00	0.37	0.37	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	6.91	0.00	6.91	1.15	2.30	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	8.44	0.38	2.30	0.00	0.00	1.54	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	14.15	0.57	3.40	1.70	0.00	1.70	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	6.56	0.82	0.82	0.00	0.00	0.82	0.82	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	9.49	0.00	6.78	0.45	0.00	0.90	0.45	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	7.90	0.00	4.31	1.44	0.00	0.72	0.72	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	10.46	0.75	1.49	0.75	1.49	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	10.78	0.37	5.57	2.60	0.74	0.00	0.37	0.00	0.37
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	9.05	0.00	1.72	0.43	0.00	0.86	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	2.57	0.00	4.28	0.00	0.00	3.43	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	10.33	0.00	7.66	1.67	0.00	0.67	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	10.86	0.00	3.62	0.00	0.00	1.81	0.60	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	10.66	0.00	2.84	0.71	0.00	0.71	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	8.25	0.69	4.47	1.72	0.00	1.72	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	5.90	0.00	0.54	0.00	0.00	0.00	1.07	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	14.81	0.00	2.02	0.67	0.00	0.67	0.67	0.00	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	8.52	0.37	3.70	2.22	0.00	1.11	0.74	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	4.65	0.00	0.00	0.00	0.00	1.16	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	8.46	0.00	8.46	0.00	0.00	2.12	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	10.80	0.40	4.00	0.80	0.00	0.40	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	6.54	0.00	1.45	0.00	0.00	0.00	0.73	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	13.80	0.00	4.60	1.53	0.00	0.77	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	13.32	0.49	4.93	1.48	0.00	2.47	0.49	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	13.17	0.94	8.47	0.94	0.94	2.82	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	8.05	0.50	4.53	0.50	0.00	0.00	0.50	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	10.36	0.45	5.86	0.45	0.45	1.80	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	8.61	0.00	6.88	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	16.03	0.45	4.90	1.34	0.00	0.45	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	10.17	0.00	5.47	1.17	0.39	1.17	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	5.94	0.00	0.66	0.66	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	13.49	0.00	4.15	0.52	0.52	0.00	0.00	0.00	0.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	10.06	0.00	6.56	2.19	0.44	1.31	0.44	0.00	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	6.15	0.00	3.35	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	8.39	0.44	3.53	0.44	0.00	0.44	0.44	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	8.49	0.00	3.09	0.77	0.39	0.77	0.39	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	6.58	0.00	1.52	0.00	0.00	2.03	1.01	0.51	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	5.77	0.00	2.40	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	10.34	0.00	3.58	0.80	0.40	1.19	0.80	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	5.47	0.00	4.25	1.22	0.00	1.22	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	9.68	0.00	7.61	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	8.36	0.00	4.18	1.14	0.38	0.76	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	7.23	0.00	4.65	0.00	0.00	1.55	0.52	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	4.84	0.00	3.02	0.00	0.00	0.60	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	8.87	0.32	3.17	1.27	0.00	0.63	0.32	0.32	0.32
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	8.00	0.00	4.80	0.53	0.00	0.00	0.53	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	3.45	0.00	5.75	0.57	0.57	0.57	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	9.77	0.51	7.20	2.06	0.51	0.51	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	12.03	0.00	3.54	0.71	0.71	0.71	0.71	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	6.24	0.57	5.67	2.27	0.00	1.13	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	15.39	0.42	3.74	0.83	0.00	2.08	0.42	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	10.96	1.57	7.05	0.78	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	8.77	0.00	6.68	0.84	0.00	0.84	0.00	0.00	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	11.15	0.00	5.58	1.39	1.39	0.46	0.00	0.00	0.46
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	8.03	0.67	4.01	0.67	0.00	1.34	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	7.48	0.00	3.21	1.07	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	14.14	0.81	3.64	0.81	0.81	0.40	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	10.10	0.00	1.84	0.92	0.00	0.92	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	9.78	0.00	6.22	1.78	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	11.97	0.00	1.14	1.71	0.00	1.14	0.57	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	13.80	0.00	2.30	0.00	1.53	0.77	2.30	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	5.47	0.55	2.19	0.55	0.00	2.19	0.55	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	12.47	0.00	4.01	0.00	0.00	0.45	0.00	0.00	0.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	8.32	0.00	2.86	0.00	0.26	0.26	0.00	0.00	0.26
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	10.61	0.00	0.66	0.00	0.00	1.33	0.00	0.66	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	12.47	0.00	4.16	2.08	0.00	6.24	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	12.54	0.23	0.23	0.23	0.46	0.23	0.00	0.00	0.00
Macrophage - monocyte derived, donor2	11313-117C8	8.44	0.00	0.92	0.18	0.00	0.00	0.18	0.00	0.00
Macrophage - monocyte derived, donor3	11389-118C3	12.58	0.13	0.39	0.26	0.00	0.26	0.00	0.00	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	3.72	1.06	0.53	0.00	0.00	0.00	0.00	0.53	0.00
Mallassez-derived cells, donor2	11929-125I3	12.68	0.79	0.63	1.11	0.32	0.48	0.32	0.00	0.00
Mallassez-derived cells, donor3	11930-125I4	11.26	1.95	1.25	0.00	0.56	0.69	0.28	0.14	0.00
Mammary Epithelial Cell, donor1	11273-116H4	10.16	2.99	1.89	0.40	0.90	0.40	0.00	0.00	0.10
Mammary Epithelial Cell, donor2	11350-117G9	10.13	1.16	0.58	0.29	0.87	0.58	0.00	0.00	0.00
Mammary Epithelial Cell, donor3	11422-118F9	14.97	0.50	0.75	0.25	0.75	0.25	0.25	0.00	0.00
Mast cell - stimulated, donor1	11487-119E2	2.03	1.36	0.68	3.39	0.68	0.00	0.00	0.00	0.00
Mast cell, donor1	11563-120D6	16.55	0.54	0.32	0.65	0.43	0.22	1.08	0.22	0.32
Mast cell, donor2	11565-120D8	9.51	0.30	2.38	0.59	0.00	0.89	0.00	0.00	0.00
Mast cell, donor3	11566-120D9	19.36	1.58	1.80	0.90	0.00	0.45	0.23	0.00	0.23
Mast cell, donor4	11567-120E1	14.01	0.71	2.66	0.53	0.18	0.18	0.18	0.18	0.35
Mast cell, expanded and stimulated, donor5	11940-126A5	16.86	0.33	0.22	1.33	0.11	0.44	0.67	0.00	0.00
Mast cell, expanded and stimulated, donor8	11942-126A7	12.84	0.58	0.00	2.92	0.00	1.75	2.92	1.17	0.00
Mast cell, expanded, donor5	11939-126A4	16.86	0.34	0.57	0.34	0.46	0.69	0.46	0.11	0.00
Mast cell, expanded, donor8	11941-126A6	20.42	0.67	0.33	1.51	1.00	0.67	1.51	0.17	0.00
Melanocyte - dark, donor1	11502-119F8	17.61	0.00	0.50	0.30	0.80	0.20	0.00	0.20	0.20
Melanocyte - dark, donor2	11582-120F7	21.11	1.04	0.00	1.04	0.00	0.00	0.00	0.00	1.04
Melanocyte - dark, donor3	11663-122F7	38.10	0.58	1.38	1.01	1.96	0.87	0.51	0.14	2.54
Melanocyte - light, donor1	11274-116H5	42.78	0.94	1.41	1.88	2.12	0.47	3.06	0.00	1.65
Melanocyte - light, donor2	11351-117H1	38.22	0.68	2.05	3.41	1.36	0.00	0.68	0.00	2.05
Melanocyte - light, donor3	11423-118G1	22.55	0.00	0.00	2.60	1.73	1.73	1.73	0.00	0.87
Melanocyte, donor1 (MC+1)	12641-134G4	31.45	0.83	0.62	1.77	1.46	1.87	1.98	0.00	1.56
Melanocyte, donor2 (MC+2)	12739-135I3	20.98	1.08	1.88	1.34	0.81	1.34	1.08	0.00	2.42
Melanocyte, donor3 (MC+3)	12837-137B2	31.07	0.54	0.80	1.87	1.87	1.07	2.68	0.00	1.34
Meningeal Cells, donor1	11493-119E8	35.48	0.37	1.98	0.50	0.25	0.37	0.50	0.12	0.62
Meningeal Cells, donor2	11573-120E7	25.09	0.00	1.32	1.32	0.00	2.20	0.44	0.00	0.44
Meningeal Cells, donor3	11654-122E7	25.67	0.33	0.90	1.47	0.41	0.65	0.24	0.08	0.16
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	21.96	2.85	0.57	0.57	1.43	0.57	0.57	0.29	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	15.40	2.72	1.01	0.30	0.30	0.40	0.20	0.10	0.10
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	42.05	0.00	6.57	1.31	2.63	1.31	1.31	0.00	1.31
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	34.01	0.00	0.00	1.31	1.31	0.00	0.00	2.62	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	25.12	2.15	0.00	2.15	0.72	0.00	0.72	0.00	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	18.00	1.48	0.21	0.64	0.64	0.00	0.85	0.21	0.21
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	15.08	1.01	0.50	0.50	0.50	0.00	2.01	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	33.40	1.32	1.32	0.88	1.54	0.88	0.22	0.00	0.44
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	27.76	2.19	0.73	2.19	0.73	0.73	0.73	0.00	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	33.96	0.41	1.43	1.64	0.41	1.64	0.61	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	19.11	1.25	1.52	0.42	0.42	0.28	1.11	0.14	0.14
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	26.39	1.49	0.74	1.12	0.74	1.49	0.37	1.12	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	25.53	1.97	0.53	0.92	0.53	0.66	0.26	0.13	0.26
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	28.49	4.75	0.89	0.59	0.89	0.30	0.30	0.30	0.89
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	25.69	0.00	2.34	0.00	2.34	2.34	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	34.58	1.28	0.64	2.56	1.28	0.64	0.00	0.00	0.64
Mesenchymal stem cells - adipose, donor0	11217-116B2	13.82	1.06	0.00	0.35	0.35	0.35	0.35	0.00	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	20.95	2.81	0.63	1.88	0.31	1.25	0.31	0.00	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	10.16	0.73	0.00	0.73	2.18	1.45	0.00	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	14.85	5.83	0.27	0.80	0.00	0.27	0.00	0.27	0.00
Mesothelial Cells, donor2	12156-128G5	14.51	5.51	0.00	0.50	0.00	0.00	0.00	0.50	0.50
Mesothelial Cells, donor3	11402-118D7	16.48	3.04	0.36	0.79	0.07	0.72	0.43	0.14	0.14
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	4.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	9.36	0.00	1.23	0.00	0.00	0.49	0.25	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	6.77	0.29	0.59	0.59	0.00	0.29	0.00	0.00	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	6.91	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	6.51	0.31	0.62	0.00	0.62	0.00	0.00	0.00	0.31
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	6.22	0.00	1.04	0.41	0.00	0.41	0.41	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	11.58	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	10.26	0.25	0.00	1.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	6.05	0.00	0.00	0.00	0.00	0.47	0.47	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	7.52	0.61	0.61	0.61	0.00	0.20	0.20	0.00	0.20
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	7.52	0.40	0.00	0.40	0.00	0.40	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	8.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	5.31	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	8.36	0.00	0.76	0.00	0.00	0.38	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	1.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	7.64	0.00	0.64	0.64	0.00	0.42	0.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	1.84	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	4.17	0.00	0.30	0.00	0.00	0.30	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	6.71	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	2.51	0.25	0.25	0.00	0.00	0.50	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	3.33	0.24	0.24	0.00	0.24	0.00	0.24	0.00	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	2.76	0.00	0.00	0.55	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	5.76	0.00	0.23	0.69	0.46	0.23	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	5.68	0.00	0.42	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	4.48	0.00	0.41	0.20	0.20	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	5.36	0.00	0.43	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	3.11	0.00	0.67	0.00	0.00	0.44	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	3.50	0.00	0.00	0.22	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	5.58	0.00	0.51	0.51	0.00	0.51	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	6.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	5.98	0.00	0.00	0.27	0.27	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	2.65	0.00	0.59	0.00	0.00	0.29	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	5.45	0.00	0.00	1.09	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	4.32	0.48	0.48	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	3.20	0.00	0.40	0.40	0.00	0.40	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	1.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	2.00	1.00	0.50	0.00	0.00	0.50	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	2.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	3.07	0.00	0.44	0.44	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	2.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	3.84	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	4.21	0.00	0.00	0.00	0.00	0.25	0.25	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	2.78	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	6.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	3.42	0.34	0.34	0.34	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	3.94	0.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	3.20	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	3.37	0.00	0.00	0.84	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	4.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	4.66	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	6.03	0.00	0.00	0.00	0.00	0.30	0.30	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	5.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	7.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	5.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	1.14	0.00	0.00	0.57	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	3.04	0.28	0.41	0.00	0.14	0.14	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	5.70	0.52	0.26	0.00	0.26	0.00	0.26	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	2.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	7.62	0.00	0.00	0.00	0.00	0.00	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	5.87	0.00	0.53	0.00	0.00	0.00	0.27	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	7.48	0.60	0.30	0.60	0.00	0.60	0.30	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	5.93	0.00	0.28	0.14	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	8.28	0.00	0.00	0.00	0.00	0.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	3.76	0.00	0.44	0.22	0.00	0.44	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	5.69	0.00	0.76	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	5.97	0.00	0.00	0.00	0.28	0.00	0.57	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	8.36	0.49	1.47	0.49	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	11.73	0.00	0.65	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	9.11	0.29	0.29	0.00	0.59	0.29	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	8.65	0.00	0.29	0.29	0.58	0.58	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	8.24	0.41	0.82	0.00	0.41	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	8.34	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	0.00	0.00	3.77	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	3.56	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	6.90	0.00	0.00	0.33	0.00	1.31	0.33	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	6.31	1.05	0.00	0.00	0.00	1.05	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	3.56	0.00	0.99	0.20	0.00	0.00	0.20	0.00	0.20
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	6.52	0.00	0.93	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	7.51	0.00	1.50	0.75	0.38	0.00	0.75	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	6.66	0.00	2.13	0.00	0.00	0.27	0.27	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	7.69	0.11	0.34	0.23	0.00	0.23	0.11	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	7.37	0.00	0.00	0.74	0.74	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	9.16	0.00	0.73	0.37	0.00	0.37	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	10.89	0.00	0.00	0.00	0.00	1.56	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	6.41	0.00	0.53	0.53	0.00	0.00	0.00	0.00	0.53
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	0.00	0.00	0.00	0.00	0.00	3.86	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	9.09	0.00	0.00	1.01	0.00	0.00	1.01	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	7.17	0.42	1.69	0.84	0.00	0.42	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	5.45	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	2.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	1.62	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	7.55	0.00	1.51	1.51	0.00	0.00	1.51	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	9.79	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	4.75	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	18.53	1.08	0.65	1.94	0.43	0.43	0.43	0.22	0.43
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	22.99	0.52	1.57	2.09	1.05	0.52	1.05	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	6.01	0.00	0.00	0.67	0.00	0.00	1.33	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	5.84	0.83	0.00	0.00	0.00	0.00	0.00	0.00	0.42
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	29.85	1.52	0.19	1.90	0.76	0.38	2.09	0.00	0.57
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	15.96	1.60	0.00	0.00	0.00	0.00	1.60	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	3.40	0.00	0.68	0.00	0.00	0.00	1.36	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	20.21	12.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	4.60	0.42	0.42	0.84	0.42	1.26	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	8.37	0.23	0.23	0.93	0.00	0.46	1.63	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	8.11	0.00	0.27	0.54	0.27	0.27	0.27	0.00	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	10.93	0.42	1.05	0.00	0.42	0.00	0.42	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	0.00	77.94	0.00	0.00	0.00	0.00	11.13	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	6.45	0.50	0.00	0.99	0.99	0.00	0.99	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	8.93	0.54	0.27	1.62	0.27	1.08	2.44	0.00	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	4.99	0.45	0.23	0.91	0.45	0.45	0.00	0.00	0.23
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	9.14	0.16	0.16	0.82	0.49	0.33	0.33	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	7.47	0.36	0.18	0.36	0.36	0.55	0.00	0.00	0.18
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	4.24	0.53	1.59	0.53	0.53	0.00	0.53	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	3.60	0.00	0.00	0.60	0.60	0.00	0.00	0.00	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	21.66	1.97	0.98	3.61	0.33	0.33	0.66	0.00	0.33
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	5.53	0.16	0.65	0.16	0.00	0.98	0.49	0.00	0.16
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	11.29	1.06	0.35	0.18	0.53	0.53	0.00	0.00	0.18
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	1.41	0.70	0.00	0.70	0.70	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	5.52	0.00	0.92	0.92	0.92	0.46	0.46	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	4.50	0.00	0.00	0.32	0.64	0.32	1.29	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	21.73	3.45	1.38	3.10	1.38	0.34	2.07	0.00	0.34
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	37.93	12.64	2.53	2.53	2.53	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	10.25	1.11	0.67	0.22	0.00	0.22	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	4.66	0.42	0.42	0.00	0.00	0.85	1.69	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	8.54	0.47	0.00	0.95	0.71	0.47	0.71	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	5.15	0.00	0.00	0.43	0.00	1.72	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	18.06	9.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	5.66	0.67	0.00	0.33	1.67	0.00	0.67	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	9.02	0.90	0.00	0.45	0.90	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	5.95	0.00	0.00	0.79	0.79	0.00	0.79	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	5.57	0.00	0.93	0.00	0.00	0.93	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	5.30	0.00	0.00	1.89	0.76	0.38	0.76	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	5.54	0.33	0.33	1.30	0.33	1.96	1.30	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	6.54	0.87	0.87	0.87	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	9.05	0.90	0.00	0.45	0.45	0.45	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	9.70	0.00	0.88	0.00	0.00	1.76	0.00	0.00	0.88
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	7.31	1.33	0.66	0.66	0.66	0.66	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	5.95	0.00	0.00	0.99	0.00	1.49	0.99	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	4.98	0.00	0.00	0.00	0.00	1.15	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	17.54	0.60	1.51	1.51	0.91	0.60	0.30	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	13.26	0.44	0.00	0.44	0.44	0.44	0.22	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	2.03	0.68	0.00	0.68	1.36	0.68	0.68	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	10.22	10.22	0.00	0.00	5.11	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	4.88	0.00	0.00	1.22	0.61	0.61	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	5.04	0.31	0.63	0.31	0.00	0.63	0.63	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	6.96	0.30	0.30	0.61	0.00	0.91	0.91	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	4.75	0.79	0.00	2.37	0.00	3.16	1.58	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	20.41	2.27	1.13	7.94	2.27	0.00	3.40	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	10.12	15.17	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	17.14	0.99	0.37	0.99	0.37	1.24	0.37	0.00	0.00
Myoblast, donor2	11322-117D8	20.14	2.30	1.34	1.73	0.38	1.92	0.19	0.00	0.19
Myoblast, donor3	11398-118D3	19.68	1.51	1.51	0.67	0.34	0.34	0.17	0.00	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	10.65	0.00	7.73	0.73	0.29	0.00	0.29	0.15	0.00
Natural Killer Cells, donor1	11230-116C6	15.38	0.00	0.31	0.31	0.00	0.31	0.00	0.00	0.00
Natural Killer Cells, donor2	11311-117C6	13.57	0.00	0.60	2.11	0.30	0.30	0.90	0.00	0.00
Natural Killer Cells, donor3	11387-118C1	9.75	0.18	0.37	0.18	0.00	0.37	0.00	0.00	0.00
Neural stem cells, donor1	11275-116H6	21.78	1.09	1.45	2.54	3.27	1.09	3.63	0.00	1.45
Neural stem cells, donor2	11352-117H2	28.88	0.00	0.00	1.93	1.93	0.00	0.00	0.00	0.00
Neurons, donor1	11494-119E9	23.90	0.00	2.28	2.28	1.14	2.28	0.00	0.00	0.00
Neurons, donor2	11574-120E8	31.92	0.00	1.10	1.10	1.32	0.44	1.76	0.22	0.44
Neurons, donor3	11655-122E8	13.98	0.82	0.00	4.11	3.29	2.47	1.64	0.00	0.00
Neutrophils, donor1	11233-116C9	26.91	0.00	0.93	3.71	0.00	3.71	2.78	0.93	0.00
Neutrophils, donor2	11314-117C9	23.19	0.00	0.00	17.39	0.00	5.80	2.90	0.00	0.00
Neutrophils, donor3	11390-118C4	36.04	0.00	1.22	0.61	0.00	0.61	3.05	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	27.19	4.75	3.09	0.83	1.78	1.07	0.24	0.36	0.83
Nucleus Pulposus Cell, donor2	11409-118E5	29.63	0.65	2.28	1.63	0.98	1.30	0.65	0.00	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	16.85	0.60	1.00	0.20	0.20	1.20	0.20	0.00	0.20
Olfactory epithelial cells, donor1	11933-125I7	10.46	2.62	1.65	0.55	0.55	1.10	0.96	0.00	0.28
Olfactory epithelial cells, donor2	11934-125I8	10.57	0.87	1.88	1.30	0.58	1.16	1.16	0.00	0.14
Olfactory epithelial cells, donor3	11935-125I9	13.51	1.25	1.59	1.25	0.68	1.14	2.27	0.00	0.34
Olfactory epithelial cells, donor4	11936-126A1	16.27	4.97	0.58	1.07	0.39	0.58	0.88	0.00	0.29
Oligodendrocyte - precursors, donor1	11496-119F2	24.67	6.02	1.20	0.60	1.81	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	25.31	0.43	0.85	0.43	0.43	0.21	0.21	0.00	0.00
Osteoblast - differentiated, donor2	11353-117H3	19.43	0.00	1.14	2.29	0.00	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	18.00	0.00	1.24	0.62	0.62	0.62	0.62	0.00	0.00
Osteoblast, donor1	11277-116H8	29.12	1.95	1.95	0.00	0.39	0.78	0.78	0.20	0.78
Osteoblast, donor2	11354-117H4	16.15	0.00	2.11	1.40	1.40	0.00	1.40	0.00	1.40
Osteoblast, donor3	11426-118G4	30.39	1.24	0.00	0.53	0.18	0.18	0.36	0.00	0.18
Pancreatic stromal cells, donor1	11249-116E7	20.22	4.72	1.18	1.26	0.34	0.76	1.68	0.00	0.17
Pericytes, donor1	11491-119E6	30.26	1.34	3.67	1.00	1.34	1.00	1.22	0.00	1.56
Pericytes, donor2	11571-120E5	26.94	1.13	2.04	0.68	0.45	1.36	0.91	0.00	0.68
Pericytes, donor3	11652-122E5	27.47	1.42	1.02	1.42	0.61	0.41	1.02	0.20	0.41
Perineurial Cells, donor1	11499-119F5	24.75	0.90	0.79	1.13	0.34	0.45	0.45	0.00	0.23
Perineurial Cells, donor2	11579-120F4	23.09	2.02	0.83	0.46	0.28	1.38	0.46	0.37	0.28
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	19.12	0.00	0.32	0.00	0.64	0.00	0.32	0.00	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	14.20	0.00	1.47	0.49	0.00	0.73	0.73	0.00	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	13.33	0.13	0.26	0.65	0.00	0.13	0.26	0.00	0.00
Placental Epithelial Cells, donor1	11278-116H9	5.98	1.20	0.96	0.24	0.00	0.24	0.72	0.00	0.00
Placental Epithelial Cells, donor2	11355-117H5	15.52	0.00	1.11	1.11	0.00	1.11	2.22	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	20.81	3.14	2.16	0.79	1.18	0.98	0.59	0.00	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	12.66	0.63	0.00	3.16	0.00	5.38	1.90	0.00	0.00
Preadipocyte - breast, donor1	11467-119B9	14.44	3.00	0.19	1.69	0.56	1.13	0.38	0.38	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	9.92	0.78	0.13	0.39	0.13	0.26	0.00	0.00	0.52
Preadipocyte - breast, donor2	11328-117E5	22.51	3.15	0.23	0.90	0.23	2.48	0.90	0.00	0.45
Preadipocyte - omental, donor1	11468-119C1	23.02	2.45	0.11	2.88	0.32	0.75	1.70	0.11	0.00
Preadipocyte - omental, donor2	11329-117E6	26.62	1.75	0.44	1.31	1.31	0.87	0.87	0.00	0.44
Preadipocyte - omental, donor3	11403-118D8	31.51	1.43	0.29	3.44	0.14	0.72	1.15	0.00	0.14
Preadipocyte - perirenal, donor1	11469-119C2	20.67	5.91	0.00	0.00	0.00	0.98	0.98	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	25.49	0.92	0.61	1.23	0.00	0.31	0.00	0.31	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	17.53	0.53	0.35	3.01	0.53	1.42	1.06	0.00	0.18
Preadipocyte - subcutaneous, donor3	11428-118G6	12.60	1.19	0.17	1.19	0.34	0.34	0.68	0.00	0.17
Preadipocyte - visceral, donor1	11280-116I2	12.85	1.68	0.19	1.30	0.56	0.28	1.02	0.19	0.09
Preadipocyte - visceral, donor2	11357-117H7	17.03	2.76	0.92	3.22	0.00	1.84	1.84	0.00	0.00
Preadipocyte - visceral, donor3	11429-118G7	8.15	0.52	0.21	1.15	0.31	0.52	0.84	0.10	0.10
Prostate Epithelial Cells (polarized), donor1	11253-116F2	11.46	4.98	1.06	2.11	1.96	1.36	2.41	4.98	1.66
Prostate Epithelial Cells, donor2	11331-117E8	20.18	1.22	1.35	1.62	0.41	1.08	1.76	0.14	0.14
Prostate Epithelial Cells, donor3	11404-118D9	8.94	2.27	0.49	0.98	0.31	0.49	0.61	0.00	0.18
Prostate Stromal Cells, donor1	11254-116F3	17.88	5.35	0.46	0.80	0.34	1.03	1.59	0.11	0.00
Prostate Stromal Cells, donor2	11332-117E9	22.23	1.61	0.54	2.69	0.36	1.79	1.97	0.00	0.36
Prostate Stromal Cells, donor3	11405-118E1	22.73	2.92	0.83	2.92	0.42	0.94	2.40	0.00	0.10
Renal Cortical Epithelial Cells, donor1	11516-119H4	20.80	1.82	0.73	0.36	2.92	1.46	0.36	0.00	1.46
Renal Cortical Epithelial Cells, donor2	11596-120H3	16.57	0.35	1.46	0.55	0.62	0.69	0.28	0.00	0.00
Renal Epithelial Cells, donor1	11517-119H5	36.01	1.01	2.54	0.00	0.51	0.00	0.51	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	26.32	0.71	0.71	0.71	0.71	0.00	0.71	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	24.77	0.64	1.69	1.16	0.85	0.85	0.53	0.00	0.00
Renal Glomerular Endothelial Cells, donor1	11514-119H2	15.66	0.00	1.36	0.68	0.68	0.68	0.00	0.68	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	10.51	0.13	0.13	1.21	0.00	0.13	0.54	0.00	0.13
Renal Glomerular Endothelial Cells, donor3	11675-122H1	22.65	0.67	0.22	0.44	0.44	0.22	0.22	0.00	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	23.96	0.00	2.00	1.33	0.00	1.33	2.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	27.29	0.66	1.10	0.88	0.44	0.66	0.22	0.22	0.22
Renal Mesangial Cells, donor2	11598-120H5	30.72	0.00	0.63	1.25	0.63	0.00	0.00	0.00	0.63
Renal Mesangial Cells, donor3	11679-122H5	26.91	1.39	1.94	0.28	0.83	0.55	0.28	0.28	0.83
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	22.82	0.81	2.15	0.54	0.27	0.00	0.54	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	12.65	0.00	1.27	0.42	0.00	0.00	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	29.89	0.58	1.16	0.77	0.96	0.19	0.39	0.00	0.19
Retinal Pigment Epithelial Cells, donor0	11215-116A9	18.93	0.52	1.04	1.30	0.52	0.52	0.52	0.26	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	22.74	1.71	1.42	0.57	2.27	0.00	0.28	0.00	0.57
Retinal Pigment Epithelial Cells, donor2	11608-120I6	22.64	0.00	1.03	0.00	1.03	1.03	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	22.33	0.75	3.26	1.25	1.25	0.50	0.50	0.00	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	13.50	2.27	0.67	0.80	0.13	0.40	1.07	5.61	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	13.40	0.00	0.00	1.79	0.00	0.00	1.79	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	15.41	0.00	2.20	3.85	0.55	1.65	2.75	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	17.40	0.00	1.16	2.32	1.74	0.00	0.00	0.00	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	15.34	0.13	0.39	1.17	0.00	0.13	0.39	0.13	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	19.86	0.00	0.50	0.99	0.60	0.60	0.79	0.00	0.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	21.19	0.11	0.78	0.22	0.22	0.67	0.45	0.00	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	26.17	0.37	1.24	2.11	0.12	0.99	0.87	0.00	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	22.96	0.00	0.12	2.10	0.23	1.17	1.40	0.00	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	20.57	0.00	0.23	2.54	0.23	0.69	0.69	0.00	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	17.52	0.00	0.27	0.68	0.14	0.96	0.68	0.00	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	20.72	0.15	0.45	2.12	0.30	2.12	0.76	0.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	16.31	0.00	0.18	0.72	0.36	0.18	0.54	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	19.94	0.29	0.72	0.43	0.29	0.86	0.72	0.00	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	24.25	0.11	0.54	1.07	0.64	1.18	0.54	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	20.58	0.00	0.66	1.77	0.44	1.55	1.11	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	16.44	0.00	0.38	1.53	0.38	0.57	0.38	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	19.38	0.19	0.28	1.30	0.09	0.84	0.84	0.09	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	22.36	0.38	0.38	1.50	0.38	0.38	1.50	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	22.43	0.13	0.00	0.53	0.00	0.27	0.66	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	22.19	0.00	0.39	0.88	0.39	1.27	0.58	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	25.78	0.00	0.38	1.15	0.38	0.76	0.95	0.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	19.97	0.00	0.21	1.07	0.21	0.43	0.21	0.00	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	19.62	0.28	1.12	1.96	0.56	1.40	0.84	0.00	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	24.10	0.00	0.17	1.37	0.34	0.51	0.85	0.00	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	15.86	0.00	0.00	0.36	0.18	0.18	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	23.42	0.12	0.49	1.72	0.25	1.23	0.86	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	27.27	0.00	0.27	1.34	0.40	1.61	0.13	0.00	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	17.93	0.00	0.47	1.65	0.00	0.00	0.94	0.00	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	22.02	0.20	0.60	1.39	0.40	1.19	1.19	0.00	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	25.49	0.00	0.00	1.40	0.70	0.47	0.47	0.00	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	17.42	0.00	0.41	0.83	0.00	0.21	0.83	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	24.78	0.00	0.66	2.65	0.44	1.99	1.99	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	21.93	0.00	1.04	1.46	0.21	1.04	0.84	0.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	20.19	0.00	0.54	1.21	0.00	0.67	0.54	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	19.92	0.00	0.17	0.51	0.17	0.51	0.68	0.00	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	23.91	0.00	0.00	1.54	0.77	0.77	0.39	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	17.54	0.17	0.17	1.38	0.00	0.86	0.34	0.17	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	22.36	0.14	0.27	0.82	0.00	0.41	0.41	0.00	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	25.77	0.00	0.16	0.99	0.66	2.46	0.33	0.16	0.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	21.30	0.00	0.51	1.02	0.17	0.68	1.02	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	22.05	0.44	0.44	1.48	0.15	0.74	0.44	0.00	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	27.72	0.00	0.53	0.53	0.00	0.53	0.27	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	17.28	0.00	0.00	1.38	0.00	0.69	0.28	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	19.29	0.00	0.71	0.48	0.48	1.43	1.19	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	32.85	0.00	0.40	1.41	1.01	1.01	0.60	0.00	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	21.66	0.19	0.66	1.70	0.28	1.32	0.57	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	23.41	0.00	1.75	2.79	1.05	0.70	1.75	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	17.53	0.00	0.30	0.91	0.91	0.60	0.60	0.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	20.44	0.24	0.49	2.69	0.49	0.86	2.69	0.00	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	24.16	0.00	0.58	0.58	0.87	0.87	0.87	0.00	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	25.55	0.00	0.00	0.61	0.00	0.61	1.22	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	20.19	0.00	0.60	0.60	0.00	0.60	0.60	0.00	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	30.54	0.45	0.90	4.30	0.90	2.49	5.43	0.00	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	31.45	0.30	1.20	2.40	1.50	1.80	1.20	0.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	17.48	0.24	0.83	1.53	0.47	1.30	6.02	0.00	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	21.34	0.43	0.21	2.56	0.64	1.92	2.99	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	28.25	0.00	0.60	0.60	0.00	0.00	1.20	0.00	0.00
Schwann Cells, donor1	11498-119F4	29.15	0.38	0.94	2.26	0.56	0.56	1.13	0.19	0.56
Schwann Cells, donor2	11578-120F3	23.82	3.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	27.17	0.88	0.00	0.88	1.10	0.88	0.66	0.00	0.00
Sebocyte, donor1	11220-116B5	29.03	3.83	1.10	1.10	2.74	0.00	0.00	0.55	0.00
Sebocyte, donor2	11301-117B5	19.76	1.38	1.84	2.76	0.92	1.38	0.46	0.00	0.46
Sebocyte, donor3	11378-118B1	22.05	0.82	3.09	1.65	1.24	1.44	0.41	0.00	0.62
Sertoli Cells, donor1	11255-116F4	29.82	1.66	1.66	0.00	0.00	1.66	3.31	0.00	0.00
Sertoli Cells, donor2	11333-117F1	19.77	0.00	0.00	0.00	0.00	8.47	11.30	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	12.84	3.26	2.20	1.06	3.34	0.44	0.79	0.18	0.53
Skeletal Muscle Cells, donor2	11358-117H8	19.52	0.72	0.00	2.17	1.45	0.72	0.72	0.00	0.72
Skeletal Muscle Cells, donor3	11430-118G8	35.95	0.00	1.67	1.67	0.00	3.34	1.67	0.00	0.84
Skeletal Muscle Cells, donor4	11451-119A2	15.08	0.47	0.16	0.79	0.00	0.94	0.31	0.00	0.31
Skeletal Muscle Cells, donor5	11455-119A6	12.63	0.74	0.45	0.59	0.15	0.89	0.59	0.15	0.30
Skeletal Muscle Cells, donor6	11459-119B1	18.31	0.46	0.31	0.92	0.15	0.92	0.31	0.00	0.46
Skeletal Muscle Satellite Cells, donor1	11240-116D7	21.55	3.40	2.27	1.26	1.64	1.26	1.01	0.13	0.50
Skeletal Muscle Satellite Cells, donor2	11321-117D7	25.26	2.28	2.14	1.71	0.71	1.14	0.57	0.00	0.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	21.63	0.99	0.60	0.79	0.79	0.30	0.69	0.00	0.20
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	12.89	1.18	1.35	0.84	1.01	0.25	0.51	0.17	0.25
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	25.33	0.72	0.72	0.00	0.72	0.00	0.00	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	15.14	0.14	0.55	0.69	0.14	0.83	0.00	0.14	0.14
Skin - palm, donor1	10286-104F7	13.43	2.69	2.69	0.00	0.00	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	12.11	0.29	0.00	1.59	0.14	0.86	1.01	0.00	0.14
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	12.27	0.82	0.00	0.82	0.82	0.82	0.00	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	9.09	0.39	0.26	1.04	0.26	0.52	0.65	0.00	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	11.95	0.83	0.97	0.70	0.14	0.83	0.56	0.14	0.14
Small Airway Epithelial Cells, donor2	11334-117F2	11.82	1.13	0.42	0.00	0.14	0.14	0.56	0.00	0.28
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	20.30	2.54	2.33	0.42	0.21	0.85	0.21	0.00	0.21
Small Airway Epithelial Cells, donor3	11406-118E2	8.77	0.45	0.75	0.37	0.00	0.52	0.22	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	23.14	1.54	0.31	2.47	0.00	5.25	4.32	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	13.34	0.44	0.67	0.00	0.00	0.00	0.22	0.00	0.44
Smooth Muscle Cells - Aortic, donor0	11210-116A4	29.98	3.53	1.18	0.59	0.00	0.59	0.00	0.59	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	29.61	2.21	0.66	0.44	0.22	0.22	0.44	0.22	0.22
Smooth Muscle Cells - Aortic, donor2	11360-117I1	24.41	3.15	0.39	0.00	0.39	0.39	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	20.09	5.41	0.00	0.77	0.00	0.00	0.77	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	24.02	2.00	3.00	2.00	1.00	0.00	3.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	24.35	2.79	0.53	0.93	0.93	0.27	0.40	0.27	0.13
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	16.85	1.77	0.44	2.22	0.44	1.33	1.99	0.22	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	9.47	2.18	0.26	0.38	0.26	0.26	0.00	0.13	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	18.88	0.33	0.65	0.00	0.00	0.33	0.33	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	19.49	1.48	0.59	0.30	0.00	0.00	0.30	0.00	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	15.38	0.57	0.28	0.43	0.00	0.28	0.14	0.00	0.14
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	25.70	1.79	0.33	0.65	0.33	0.65	0.49	0.16	0.16
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	25.27	2.13	0.61	0.91	0.30	0.00	0.30	0.00	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	23.24	7.83	1.26	0.51	0.25	0.25	0.00	0.00	0.25
Smooth Muscle Cells - Carotid, donor2	11362-117I3	30.60	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	20.98	0.48	0.00	0.95	0.48	2.38	0.48	0.00	0.48
Smooth Muscle Cells - Colonic, donor1	11239-116D6	9.59	1.33	0.74	0.59	0.00	0.44	0.44	0.00	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	18.30	0.86	0.22	0.43	0.22	0.43	0.86	0.00	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	15.11	1.05	0.63	0.73	0.21	0.63	0.52	0.10	0.00
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	25.52	3.09	0.62	0.77	0.62	0.31	0.46	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	26.95	2.16	2.16	2.16	0.00	1.08	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	11.95	0.90	0.90	0.30	0.00	0.30	0.60	0.00	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	33.46	1.37	0.00	1.37	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	22.07	4.16	0.71	0.63	0.94	0.63	0.08	0.08	0.39
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	17.11	1.81	0.91	2.92	0.60	0.81	2.21	0.00	0.10
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	15.93	2.96	0.91	2.28	0.46	1.37	1.14	0.00	0.68
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	24.15	0.60	0.00	1.21	0.00	1.21	0.00	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	27.82	1.06	0.00	1.06	0.26	0.26	1.06	0.00	0.26
Smooth Muscle Cells - Prostate, donor1	11257-116F6	16.78	2.00	0.27	1.73	0.00	0.40	1.46	0.27	0.27
Smooth Muscle Cells - Prostate, donor2	11335-117F3	21.79	3.88	1.00	3.63	0.38	1.50	1.63	0.13	0.00
Smooth Muscle Cells - Prostate, donor3	11465-119B7	11.41	1.78	1.27	0.00	0.51	0.00	1.78	0.00	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	22.31	1.81	0.15	0.15	0.45	0.45	0.45	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	25.51	0.00	1.50	0.00	0.00	1.50	0.00	0.00	0.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	175.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	41.39	5.58	0.47	1.86	0.93	1.40	1.40	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	22.21	2.52	0.00	2.02	0.50	2.52	0.00	0.50	1.51
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	18.80	3.45	0.00	1.88	0.00	1.88	0.94	0.00	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	25.96	4.72	0.88	1.18	0.00	0.59	0.88	0.29	0.59
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	22.08	2.42	0.33	0.33	0.42	0.08	0.00	0.08	0.33
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	12.61	0.47	0.00	1.40	0.93	0.47	0.00	0.00	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	26.34	2.73	1.01	0.14	0.00	0.14	0.43	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	27.54	0.76	0.51	0.76	0.25	0.00	0.51	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	14.10	0.56	0.00	0.94	0.75	0.75	0.19	0.00	0.38
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	19.28	1.12	0.84	0.84	0.42	0.00	0.28	0.14	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	16.84	0.84	0.50	0.08	0.08	0.50	0.00	0.00	0.08
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	14.76	0.95	0.48	0.00	0.00	0.48	0.00	0.00	0.48
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	23.24	1.22	0.00	1.96	0.73	0.24	0.73	0.00	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	13.70	2.21	0.44	1.55	0.00	0.44	1.33	0.00	0.22
Smooth Muscle Cells - Uterine, donor3	11466-119B8	16.38	0.29	1.17	0.88	0.29	1.17	0.29	0.00	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	15.16	1.36	0.58	0.97	0.78	0.58	0.58	0.00	0.39
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	12.43	0.00	0.00	2.91	0.26	1.32	2.38	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	10.41	2.23	1.12	3.35	0.00	1.86	4.09	0.37	0.37
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	21.92	1.80	3.95	2.16	0.00	3.23	0.72	0.36	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	15.90	1.99	0.00	0.85	0.00	0.57	0.28	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	9.85	0.00	1.18	1.97	0.00	1.18	2.76	0.00	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	8.89	3.05	0.76	2.03	0.51	2.79	2.54	0.00	0.76
Smooth muscle cells - airway, control, donor2	11967-126D5	11.58	3.99	0.40	2.00	0.40	0.00	1.60	0.00	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	13.38	0.42	0.00	1.25	0.00	4.18	2.09	0.00	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	14.67	0.00	0.00	1.38	0.00	0.46	0.92	0.00	0.46
Synoviocyte, donor1	11291-117A4	10.10	1.01	0.17	0.50	0.67	0.34	0.50	0.00	0.17
Synoviocyte, donor2	11368-117I9	6.70	1.84	0.84	1.34	0.00	0.67	0.50	0.00	0.00
Synoviocyte, donor3	11440-118H9	7.37	0.89	0.67	2.01	0.45	0.67	2.01	0.22	0.22
Trabecular Meshwork Cells, donor1	11532-120A2	39.66	0.36	0.36	1.07	0.36	0.71	0.00	0.00	0.36
Trabecular Meshwork Cells, donor2	11612-122A1	29.73	1.98	1.98	0.00	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	35.66	0.93	1.85	0.23	0.00	0.46	0.46	0.00	0.23
Tracheal Epithelial Cells, donor1	11292-117A5	9.32	4.44	1.15	0.14	0.29	0.14	0.14	0.00	0.14
Tracheal Epithelial Cells, donor2	11369-118A1	15.08	1.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	9.16	0.00	0.00	0.00	0.57	1.15	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	13.16	1.35	0.25	1.11	0.25	0.62	1.11	5.17	0.00
Urethra, donor2	10319-105A4	26.98	14.39	0.00	5.40	1.80	0.00	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	19.66	2.13	1.06	0.27	0.53	0.53	0.00	0.00	0.80
Urothelial Cells, donor2	11600-120H7	12.82	2.80	1.20	0.40	0.00	0.00	0.80	0.00	0.00
Urothelial Cells, donor3	11681-122H7	13.75	2.06	1.15	0.92	0.69	0.46	0.23	0.00	0.00
Urothelial cells, donor0	11216-116B1	16.05	4.46	2.67	1.11	0.22	0.89	0.00	0.00	0.22
Whole blood (ribopure), donor090309, donation1	12179-129A1	34.70	0.00	1.78	1.78	0.00	2.67	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	38.60	0.00	1.43	0.00	0.00	2.86	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	30.12	0.00	0.00	4.11	0.00	0.00	0.68	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	24.45	0.00	1.72	0.34	0.00	0.00	0.34	0.00	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	14.53	0.00	0.58	0.58	0.00	1.16	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	27.07	0.00	1.04	2.08	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	21.11	0.00	0.92	0.92	0.00	1.84	0.92	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	31.95	0.00	0.91	1.83	0.00	1.83	1.83	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	24.80	1.11	0.49	1.36	1.23	1.36	0.49	0.12	0.86
Wilms' tumor cell line:HFWT	10597-108E3	19.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	12.57	1.40	0.28	0.28	0.56	0.28	0.00	0.00	0.00
achilles tendon, donor2	10292-104G4	18.60	0.00	2.07	0.00	0.00	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	17.85	0.00	0.76	1.78	1.78	0.76	0.76	0.00	1.27
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	15.56	0.00	1.63	0.23	0.00	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	19.82	0.36	1.78	0.83	1.31	0.12	0.12	0.00	0.36
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	28.03	0.54	0.27	1.63	2.72	0.82	0.54	0.00	1.63
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	25.58	0.00	0.56	1.12	0.28	1.69	0.56	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	19.67	0.00	0.63	0.00	1.48	0.63	0.42	0.00	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	14.16	0.27	0.54	0.27	0.00	0.27	0.27	0.00	0.54
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	27.32	0.00	3.08	0.88	0.88	0.44	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	20.01	0.41	0.82	3.27	1.63	1.63	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	11.26	0.00	1.16	0.39	0.00	0.39	0.00	0.00	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	14.72	0.00	0.18	0.74	0.00	0.37	0.55	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	15.60	0.00	3.90	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	19.75	0.00	0.46	1.16	1.86	0.93	0.70	0.23	0.23
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	27.96	0.26	0.78	2.85	0.26	1.04	0.52	0.00	0.26
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	16.66	0.00	0.00	0.88	0.00	0.58	0.58	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	12.08	0.00	2.32	0.00	0.00	0.00	0.93	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	13.16	0.00	2.06	0.82	0.00	0.41	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	6.45	0.00	0.31	0.31	0.00	0.31	0.31	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	14.93	0.00	0.43	1.28	0.00	0.43	0.43	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	19.11	0.00	0.30	0.61	0.00	0.30	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	23.59	0.24	1.44	0.48	0.00	0.00	0.24	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	20.27	0.00	0.89	2.00	0.45	1.34	0.22	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	13.01	0.00	1.33	0.33	0.00	0.33	0.33	0.00	0.67
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	1.86	0.00	0.00	0.00	1.86	0.00	1.86	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	15.07	1.13	0.75	0.38	0.38	0.75	0.00	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	16.14	0.00	0.44	0.44	0.44	0.44	0.00	0.00	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	7.50	1.87	0.00	0.00	1.87	0.00	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	13.42	5.65	0.24	0.24	0.94	0.00	0.00	0.71	0.24
adipose tissue, adult, pool1	10010-101C1	14.43	1.40	1.55	0.47	0.16	0.93	1.24	0.00	0.00
adipose, donor1	10184-103D4	34.60	12.31	2.35	8.21	4.69	5.86	15.83	0.00	10.56
adipose, donor2	10185-103D5	24.33	0.81	0.00	2.84	4.06	1.22	8.92	0.81	4.46
adipose, donor3	10186-103D6	28.32	4.63	0.82	1.91	4.90	1.63	6.53	0.27	4.36
adipose, donor4	10187-103D7	20.80	2.60	3.47	3.47	0.87	0.87	5.20	0.00	3.47
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	42.30	0.32	2.05	1.42	0.47	0.95	0.32	0.00	0.00
adrenal gland, adult, pool1	10081-102A9	18.19	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	18.68	0.00	2.27	1.07	0.67	0.27	0.13	0.00	0.13
alveolar cell carcinoma cell line:SW 1573	10708-109H6	26.80	0.36	1.43	1.43	1.07	0.71	0.71	0.00	0.36
amniotic membrane cells, donor1	12235-129G3	6.49	2.55	0.46	0.00	0.00	0.46	0.46	0.23	0.00
amniotic membrane cells, donor2	12236-129G4	11.83	3.04	1.69	0.34	0.00	0.68	1.01	0.00	0.00
amniotic membrane cells, donor3	12237-129G5	9.72	1.18	1.77	0.29	0.00	0.29	0.00	0.00	0.00
amygdala - adult, donor10196	10167-103B5	41.50	0.00	0.00	1.19	0.00	0.00	1.19	0.00	0.00
amygdala, adult, donor10252	10151-102I7	45.62	0.81	0.61	0.20	0.00	0.61	0.20	0.00	0.20
amygdala, newborn, donor10223	10360-105E9	23.88	0.97	0.32	0.97	0.00	0.00	1.29	0.00	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	5.60	1.40	0.64	0.25	0.64	0.51	0.13	0.00	0.00
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	17.43	0.00	0.88	0.66	0.00	0.66	0.22	0.00	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	15.70	2.34	0.33	0.00	5.68	0.00	0.00	0.00	5.34
aorta, adult, pool1	10052-101G7	14.71	1.57	0.20	0.59	0.39	0.00	0.59	0.00	0.00
appendix, adult	10189-103D9	16.30	1.16	0.78	0.78	0.00	0.00	1.16	0.39	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	37.14	0.69	1.38	1.38	4.13	0.00	1.72	3.10	1.03
artery, adult	10190-103E1	23.10	2.72	2.72	1.36	0.00	0.00	5.43	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	19.70	2.75	1.16	1.88	1.88	0.58	0.00	0.29	1.01
b cell line:RPMI1788	10427-106D4	10.71	0.30	1.49	0.15	0.59	0.30	0.30	0.00	0.00
basal cell carcinoma cell line:TE 354.T	10702-109G9	21.92	0.28	0.00	0.83	0.00	0.83	0.28	0.00	0.55
bile duct carcinoma cell line:HuCCT1	10432-106D9	8.34	0.89	1.39	0.50	0.50	0.30	0.10	0.00	0.10
bile duct carcinoma cell line:TFK-1	10496-107C1	2.68	0.67	0.67	0.17	0.17	0.17	0.17	0.00	0.17
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	6.71	0.00	2.80	0.00	0.00	0.00	0.56	0.00	0.00
bladder, adult, pool1	10011-101C2	13.25	8.15	0.65	1.30	0.76	0.54	0.54	0.00	0.43
blood, adult, pool1	10053-101G8	19.93	0.00	0.00	0.00	0.00	0.00	2.21	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	8.56	3.43	0.86	0.00	0.86	0.00	0.00	0.00	0.00
bone marrow, adult	10192-103E3	25.64	0.00	2.02	7.42	0.00	2.02	3.37	0.00	0.00
brain, adult, donor1	10084-102B3	27.68	0.00	0.00	3.08	3.08	2.05	4.10	0.00	0.00
brain, adult, pool1	10012-101C3	35.08	1.45	1.34	1.89	1.45	0.89	1.22	0.11	0.56
brain, fetal, pool1	10085-102B4	24.04	0.00	0.00	8.01	0.00	0.00	0.00	0.00	2.67
breast carcinoma cell line:MCF7	10482-107A5	7.60	0.66	5.29	0.33	0.99	0.66	0.66	0.00	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	10.49	1.12	2.75	0.12	2.25	0.62	0.12	0.00	0.37
breast, adult, donor1	10080-102A8	10.10	0.00	0.63	0.00	0.00	0.00	1.26	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	17.91	2.67	0.76	0.51	1.40	0.25	0.25	0.00	0.38
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	6.80	0.93	0.31	0.00	0.31	0.31	0.00	0.00	0.31
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	31.08	2.99	0.23	4.14	1.84	1.84	2.53	0.00	0.69
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	11.14	0.48	0.73	0.24	0.00	0.24	0.73	0.00	0.00
carcinoid cell line:NCI-H1770	10703-109H1	13.63	0.94	1.41	1.88	3.76	1.41	0.94	0.00	0.94
carcinoid cell line:NCI-H727	10735-110B6	12.58	0.88	1.53	0.77	0.22	0.22	0.22	0.55	0.33
carcinoid cell line:SK-PN-DW	10719-109I8	25.03	0.32	0.32	1.90	5.70	0.63	1.27	0.00	3.80
carcinosarcoma cell line:JHUCS-1	10642-109A3	24.22	0.27	3.73	1.86	3.46	2.93	2.40	0.27	3.46
caudate nucleus - adult, donor10196	10177-103C6	13.82	3.45	0.00	2.30	1.15	3.45	0.00	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	46.01	2.34	0.67	1.00	0.67	0.50	0.67	0.00	0.17
caudate nucleus, adult, donor10258	10379-105H1	32.09	0.00	1.53	3.82	0.00	0.76	2.29	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	20.51	2.20	0.73	2.56	0.37	0.73	2.56	0.00	0.73
cerebellum - adult, donor10196	10173-103C2	11.65	0.00	2.91	0.00	2.91	0.00	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	42.92	0.00	0.43	2.35	0.00	0.43	0.64	0.00	0.00
cerebellum, adult, pool1	10083-102B2	20.70	0.34	0.34	0.69	0.00	1.03	1.03	0.00	0.00
cerebellum, newborn, donor10223	10357-105E6	25.74	0.00	1.66	1.66	0.00	1.66	1.66	0.00	0.00
cerebral meninges, adult	10188-103D8	29.75	2.02	0.76	1.26	0.00	0.76	1.01	0.00	0.00
cerebrospinal fluid, donor2	10294-104G6	13.16	2.92	0.73	0.73	0.00	0.00	1.46	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	37.38	0.14	1.73	1.58	0.29	0.29	0.72	0.00	0.00
cervical cancer cell line:ME-180	10553-107I4	8.78	1.99	0.50	0.66	0.66	0.00	0.50	0.00	0.00
cervix, adult, pool1	10013-101C4	21.42	2.31	0.73	1.78	1.26	0.94	0.52	0.00	0.73
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	11.98	2.93	0.14	1.11	0.42	0.00	0.98	0.00	0.00
chondrosarcoma cell line:SW 1353	10700-109G7	5.23	3.92	0.00	0.00	0.00	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	33.68	5.22	1.86	3.48	0.75	0.99	3.11	0.62	0.00
choriocarcinoma cell line:SCH	10785-110H2	17.50	11.21	1.23	0.86	0.49	0.49	0.99	0.25	0.86
choriocarcinoma cell line:T3M-3	10618-108G6	19.45	1.90	1.42	0.95	0.24	0.00	0.24	0.00	0.00
chorionic membrane cells, donor1	12238-129G6	9.69	5.98	0.28	0.57	0.28	0.28	0.57	0.28	0.00
chorionic membrane cells, donor2	12239-129G7	22.87	1.89	0.80	1.19	0.50	0.99	1.59	0.20	0.20
chorionic membrane cells, donor3	12240-129G8	16.48	3.85	0.55	0.00	0.55	2.20	1.65	0.55	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	7.07	0.00	1.01	1.01	0.00	1.01	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	19.40	0.00	0.58	0.58	0.00	0.19	0.38	0.00	0.38
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	21.12	1.06	0.42	0.63	0.21	0.63	0.42	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	45.20	2.57	2.31	1.80	0.26	1.03	0.77	0.26	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	47.65	2.66	2.42	1.21	0.73	0.00	0.48	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	38.48	2.04	2.85	2.24	0.20	1.22	0.00	0.41	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	28.27	1.18	0.88	1.47	0.29	1.77	1.18	0.00	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	29.45	0.52	0.26	1.30	1.30	0.00	0.26	0.00	0.78
clear cell carcinoma cell line:JHOC-5	10638-108I8	12.34	0.00	0.46	2.29	0.23	1.14	1.60	0.00	0.00
clear cell carcinoma cell line:TEN	10636-108I6	15.44	0.17	0.17	1.04	0.35	0.35	0.35	0.00	0.17
colon carcinoma cell line:CACO-2	10513-107D9	17.39	2.01	1.46	1.46	0.18	0.55	0.00	5.31	1.46
colon carcinoma cell line:COLO-320	10420-106C6	23.57	0.76	6.84	1.14	5.70	0.38	0.00	0.00	0.38
colon, adult, donor1	10082-102B1	7.14	0.00	0.00	1.19	0.00	0.00	1.19	1.19	0.00
colon, adult, pool1	10014-101C5	18.68	2.94	0.35	0.71	0.35	0.94	1.65	19.04	0.35
colon, fetal, donor1	10070-101I7	13.60	1.85	1.24	1.85	0.62	0.62	0.62	3.71	0.62
common myeloid progenitor CMP, donor1	12130-128D6	32.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	10.62	2.12	0.42	0.85	0.85	0.00	0.00	0.00	0.42
cord blood derived cell line:COBL-a 24h infection	10453-106G3	14.94	0.60	0.30	0.30	3.17	0.15	0.45	0.15	0.91
cord blood derived cell line:COBL-a untreated	10449-106F8	12.27	1.27	0.56	0.42	4.37	0.14	0.56	0.00	0.71
corpus callosum, adult, pool1	10042-101F6	40.13	1.11	1.99	1.11	1.99	0.33	0.44	0.44	1.77
cruciate ligament, donor2	10295-104G7	9.73	1.62	0.00	1.62	0.00	0.00	0.00	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	20.87	0.80	0.00	2.41	0.00	0.00	0.80	0.00	0.00
diencephalon, adult	10193-103E4	28.56	0.96	0.24	0.72	1.68	0.48	0.96	0.24	1.20
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	10.33	0.00	1.38	2.30	1.15	0.92	0.00	0.00	0.46
ductal cell carcinoma cell line:KLM-1	10438-106E6	13.08	1.80	1.03	0.26	0.77	0.77	0.00	0.00	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	21.91	5.78	3.61	0.72	1.20	0.72	1.20	0.00	0.96
ductus deferens, adult	10196-103E7	29.40	3.49	0.50	1.00	1.50	0.50	1.00	0.00	0.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	8.64	0.00	1.44	1.44	0.00	2.88	1.44	4.32	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	25.01	0.74	0.74	4.41	0.74	1.47	2.94	9.56	0.00
dura mater, adult, donor1	10041-101F5	13.38	8.09	0.91	0.41	0.91	0.08	0.50	0.00	0.08
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	20.43	1.33	7.55	1.11	3.11	0.89	2.22	0.00	0.44
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	47.43	0.14	6.02	2.87	2.58	1.29	3.30	0.00	0.43
embryonic pancreas cell line:1B2C6	10604-108F1	13.57	2.47	0.00	1.23	0.00	0.00	0.62	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	14.53	1.51	0.30	0.61	0.30	0.00	0.30	0.30	0.30
embryonic pancreas cell line:1C3IKEI	10606-108F3	9.57	2.78	0.93	0.00	0.62	0.31	0.62	0.00	0.00
embryonic pancreas cell line:2C6	10603-108E9	7.88	1.31	0.00	0.00	0.00	0.00	1.31	0.00	1.31
endometrial carcinoma cell line:OMC-2	10497-107C2	16.76	4.69	2.68	0.34	2.35	0.34	0.00	0.34	1.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	17.40	0.00	1.09	2.36	0.18	0.36	1.27	0.00	0.18
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	15.44	0.00	1.13	0.48	0.32	0.64	0.48	0.00	0.00
epidermoid carcinoma cell line:A431	10426-106D3	7.34	1.56	0.33	0.22	0.11	0.11	0.00	0.00	0.11
epidermoid carcinoma cell line:Ca Ski	10431-106D8	18.04	2.75	1.32	0.33	0.66	0.44	0.22	0.00	0.00
epididymis, adult	10197-103E8	18.84	1.05	1.88	0.84	0.42	0.63	2.09	0.42	0.21
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	13.31	0.89	0.18	1.24	0.18	0.18	1.06	0.00	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	12.19	0.79	0.39	0.79	0.00	0.79	0.00	0.00	0.79
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	22.15	7.34	0.13	1.57	0.79	1.18	0.66	0.13	0.26
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	22.54	9.55	1.08	1.28	1.08	1.08	0.59	0.00	0.59
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	30.14	6.83	0.45	2.13	0.90	1.12	0.11	0.11	0.34
esophagus, adult, pool1	10015-101C6	14.02	5.10	1.38	1.49	0.64	0.42	0.64	0.00	0.11
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	17.28	0.50	1.25	0.25	0.75	0.13	0.25	0.00	0.13
eye - muscle inferior rectus, donor1	10272-104E2	28.97	7.24	0.00	4.83	0.00	0.00	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	14.73	6.31	2.10	0.00	0.00	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	16.37	8.93	0.00	1.49	0.00	0.00	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	22.93	4.59	0.00	1.15	1.15	0.00	0.00	1.15	0.00
eye - vitreous humor, donor1	10268-104D7	14.57	0.00	0.00	2.91	0.00	0.00	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	21.86	0.76	1.53	1.53	0.76	1.02	0.76	0.00	0.25
fibrosarcoma cell line:HT-1080	10758-110E2	9.87	0.77	0.77	0.64	0.90	0.26	0.38	0.00	0.77
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	32.05	1.42	0.24	1.42	1.19	2.14	0.95	0.00	1.42
frontal lobe, adult, pool1	10040-101F4	42.03	1.31	1.03	0.47	0.94	0.66	0.56	0.09	0.38
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	14.11	19.22	0.60	1.20	0.60	1.80	1.20	0.30	0.60
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	25.42	1.46	1.19	0.64	0.37	0.55	0.27	0.00	0.09
gall bladder, adult	10198-103E9	22.45	2.41	0.48	0.72	0.24	1.45	1.45	2.17	0.48
gamma delta positive T cells, donor1	11937-126A2	20.94	0.00	2.15	1.07	0.00	0.54	0.00	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	17.18	0.00	2.24	0.37	0.37	0.37	0.37	0.00	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	14.15	2.75	0.84	0.63	0.42	2.32	0.84	0.00	0.63
gastric adenocarcinoma cell line:MKN45	10612-108F9	26.88	0.97	0.58	0.97	0.58	0.77	0.97	0.39	0.00
gastric cancer cell line:AZ521	10549-107H9	31.64	0.98	1.64	1.31	0.98	0.00	0.33	0.00	0.82
gastric cancer cell line:GSS	10560-108A2	14.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	15.76	0.69	0.46	1.37	0.00	1.83	0.23	3.66	1.60
giant cell carcinoma cell line:LU65	10487-107B1	10.44	0.23	1.26	1.03	0.00	0.34	0.23	0.11	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	35.27	4.34	0.56	0.98	0.84	0.42	0.84	0.00	0.98
glassy cell carcinoma cell line:HOKUG	10688-109F4	6.24	1.00	0.75	0.50	0.25	0.25	0.25	0.00	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	10.24	1.37	0.84	0.11	0.74	0.21	0.42	0.00	0.11
glioblastoma cell line:A172, tech_rep2	10444-106F3	8.99	1.12	0.70	0.70	0.56	0.42	0.28	0.00	0.14
glioblastoma cell line:T98G	10485-107A8	19.65	3.53	0.22	0.77	1.43	0.44	0.11	0.11	0.55
glioma cell line:GI-1	10413-106B8	22.26	2.05	2.34	0.29	0.88	0.00	1.76	0.00	0.88
globus pallidus - adult, donor10196	10175-103C4	21.87	1.46	0.73	0.00	0.73	0.00	1.46	0.73	0.00
globus pallidus, adult, donor10252	10161-103A8	31.49	2.69	2.44	0.98	0.73	0.00	0.00	0.24	0.73
globus pallidus, adult, donor10258	10367-105F7	43.81	0.00	0.00	5.48	0.00	0.00	1.37	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	20.25	0.00	1.60	0.53	0.00	0.53	0.53	0.00	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	9.79	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	10.93	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	15.68	0.00	5.23	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	14.08	2.56	0.64	0.64	0.00	0.64	0.00	0.00	0.32
hIPS +CCl2, biol_rep1	14383-156B9	12.40	0.92	2.75	2.30	1.38	0.46	0.46	0.00	2.75
hIPS +CCl2, biol_rep2	14384-156C1	10.97	0.91	0.91	1.37	0.00	0.46	0.46	0.00	2.29
hIPS +CCl2, biol_rep3	14385-156C2	11.59	0.64	0.64	0.00	1.29	0.64	0.00	0.64	1.29
hIPS, biol_rep1	14380-156B6	7.19	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	6.86	0.00	0.69	0.69	0.69	0.00	1.37	0.00	0.69
hIPS, biol_rep3	14382-156B8	18.76	0.00	1.10	1.10	1.10	3.31	1.10	0.00	1.10
hairy cell leukemia cell line:Mo	10712-109I1	8.62	0.00	0.86	0.29	1.15	0.00	0.29	0.00	0.57
heart - mitral valve, adult	10205-103F7	14.65	5.98	0.00	1.20	0.90	0.90	0.30	0.00	0.60
heart - pulmonic valve, adult	10206-103F8	16.47	4.45	0.00	1.31	0.52	0.52	0.52	0.26	1.05
heart - tricuspid valve, adult	10207-103F9	9.99	3.33	0.00	0.00	0.00	0.00	0.00	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	15.71	1.84	0.82	1.84	0.20	1.02	1.02	0.00	0.00
heart, adult, diseased, donor1	10051-101G6	19.59	3.83	0.00	0.43	0.43	2.13	0.85	0.00	0.00
heart, adult, pool1	10016-101C7	21.39	5.75	0.00	0.00	0.23	0.00	0.00	0.00	0.23
heart, fetal, pool1	10046-101G1	30.09	7.08	1.23	0.72	2.46	0.21	0.31	0.51	1.54
hepatic mesenchymal tumor cell line:LI90	10778-110G4	22.21	2.16	0.00	1.54	0.00	0.31	0.93	0.00	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	10.70	3.57	0.00	0.00	0.00	0.00	0.00	2.38	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	46.63	4.64	0.77	2.54	1.88	1.55	0.22	11.71	0.55
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	48.19	4.37	0.24	4.01	0.97	0.97	0.36	14.56	1.58
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	43.96	3.84	0.91	3.54	2.02	0.81	1.11	15.26	1.21
hepatoma cell line:Li-7	10484-107A7	8.45	4.00	0.33	0.44	0.00	0.22	0.44	0.56	0.22
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	16.68	0.40	0.70	0.20	1.01	0.10	0.30	0.20	0.40
hippocampus - adult, donor10196	10169-103B7	31.23	0.00	0.00	0.00	1.89	0.00	0.00	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	42.45	0.41	1.43	1.22	0.00	0.82	0.00	0.00	0.20
hippocampus, adult, donor10258	10374-105G5	15.93	0.50	0.00	0.00	0.50	0.50	0.00	0.00	0.00
hippocampus, newborn, donor10223	10363-105F3	33.49	0.35	0.35	0.70	0.00	1.06	2.11	0.00	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	10.99	6.71	3.05	3.66	2.44	1.83	4.88	0.00	5.49
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	18.85	1.96	1.77	1.96	1.96	2.16	1.37	0.00	3.73
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	16.25	2.79	2.03	2.79	3.81	2.03	3.30	0.00	1.78
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	25.94	2.26	0.00	5.07	8.46	5.07	12.97	0.00	3.38
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	29.18	5.42	0.26	9.30	4.13	6.46	21.17	0.00	3.87
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	29.61	2.28	0.00	4.18	6.07	2.66	12.15	0.38	3.80
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	24.52	2.34	1.75	3.80	3.50	3.21	9.34	0.29	4.96
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	24.56	3.66	0.65	3.88	4.95	1.94	6.68	0.43	4.31
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	28.36	1.67	0.83	0.83	2.92	4.17	6.26	0.42	1.67
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	19.42	1.18	0.95	1.18	2.60	1.66	3.32	1.18	2.13
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	20.25	2.09	0.48	3.05	4.82	1.77	4.98	1.77	4.34
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	19.53	4.71	0.00	0.67	4.04	1.35	2.69	0.67	2.69
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	15.18	4.07	3.44	2.82	3.44	1.88	3.29	0.16	4.54
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	13.76	5.40	1.47	4.91	4.42	5.40	5.40	0.00	4.42
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	13.96	3.49	7.85	6.98	6.98	4.36	8.73	0.00	3.49
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	33.60	3.82	0.76	5.15	4.77	4.20	11.65	0.00	3.82
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	26.16	5.23	0.44	3.92	3.92	3.49	8.72	0.00	2.18
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	32.48	4.50	1.00	2.50	8.50	2.50	24.99	0.00	4.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	15.64	3.01	0.57	2.26	7.91	1.51	6.78	0.00	3.01
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	18.19	4.09	0.91	1.82	4.55	2.73	5.00	0.00	4.09
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	18.48	3.45	0.31	2.19	4.70	1.88	6.26	0.00	1.25
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	24.82	4.74	1.14	3.43	5.06	1.80	6.37	0.33	3.43
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	19.16	4.64	0.58	2.61	2.32	1.74	6.10	0.29	5.52
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	26.90	1.49	1.49	4.48	5.38	1.20	5.98	0.30	2.99
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	17.18	3.33	4.06	2.22	2.77	2.03	4.43	0.37	4.43
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	17.69	2.28	4.28	2.85	2.00	2.28	3.71	0.00	6.56
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	19.60	5.72	8.57	3.27	4.49	3.27	6.94	0.82	4.49
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	30.98	4.58	1.76	4.22	5.28	6.69	12.32	1.06	4.22
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	30.09	2.85	0.63	5.07	4.75	1.90	10.14	0.95	3.80
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	28.14	1.82	0.91	5.14	4.84	5.75	13.01	0.30	3.93
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	21.72	3.62	1.03	1.55	4.65	0.52	2.59	1.03	2.07
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	17.93	3.32	0.66	2.66	3.98	0.00	2.66	0.00	2.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	15.39	2.31	0.26	1.03	3.85	2.31	1.54	0.00	1.80
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	25.82	2.05	1.02	3.32	3.07	2.81	5.11	0.26	0.77
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	24.99	3.79	3.03	0.76	3.03	3.79	1.51	0.00	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	20.50	1.01	1.01	1.01	4.03	2.02	5.04	0.00	1.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	13.52	1.93	6.04	1.93	4.35	2.17	4.35	0.00	5.31
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	16.49	1.78	3.12	3.12	6.24	3.12	2.23	0.45	3.57
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	13.66	1.46	9.27	0.98	4.39	1.46	3.90	0.00	4.88
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	29.64	3.97	0.31	5.20	2.44	3.97	14.98	0.31	7.03
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	32.53	61.81	6.51	13.01	13.01	3.25	39.04	9.76	19.52
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	26.81	2.65	0.66	7.61	4.96	6.62	19.19	1.99	5.96
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	23.53	1.09	0.55	0.55	4.38	2.19	5.47	1.09	4.93
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	14.11	0.36	2.90	1.45	2.53	1.81	5.07	0.36	2.53
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	15.30	0.36	0.71	1.07	3.91	1.78	8.19	0.00	3.20
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	11.93	0.00	1.19	3.58	5.97	2.39	5.97	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	23.97	4.47	2.03	3.66	5.28	2.57	11.24	0.41	4.47
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	22.63	0.81	1.08	2.69	4.58	1.08	7.00	0.81	1.62
immature langerhans cells, donor1	11904-125F5	8.96	0.24	1.70	0.73	0.48	0.00	0.24	0.00	0.00
immature langerhans cells, donor2	11905-125F6	7.13	0.79	1.58	0.00	0.00	0.00	0.79	0.00	0.00
insula, adult, pool1	10039-101F3	51.48	0.57	0.47	1.70	0.57	0.85	0.76	0.00	0.57
keratoacanthoma cell line:HKA-1	10791-110H8	13.01	2.60	4.23	0.00	0.33	0.00	0.33	0.00	0.00
kidney, adult, pool1	10017-101C8	21.33	1.00	1.10	0.90	0.20	0.60	0.60	6.21	0.60
kidney, fetal, pool1	10045-101F9	28.51	0.71	1.77	0.57	1.27	0.50	0.14	4.39	0.71
large cell lung carcinoma cell line:IA-LM	10509-107D5	27.84	1.85	0.85	0.57	1.14	0.28	0.57	0.00	0.57
large cell lung carcinoma cell line:NCI-H460	10839-111E2	10.09	0.83	1.24	0.83	0.69	0.41	0.69	0.00	0.41
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	9.73	1.10	0.55	0.00	0.18	0.00	0.18	0.00	0.37
left atrium, adult, donor1	10079-102A7	9.81	4.90	0.54	1.63	1.09	0.00	0.54	0.00	0.00
left ventricle, adult, donor1	10078-102A6	9.61	1.01	0.00	1.01	0.51	0.00	0.00	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	16.14	1.09	0.00	0.00	0.82	0.00	0.27	0.00	0.27
leiomyoma cell line:10964C	10569-108B2	22.63	4.31	0.36	1.80	0.72	3.23	1.80	0.36	0.00
leiomyoma cell line:15242A	10570-108B3	23.37	1.09	0.00	0.54	0.54	3.26	1.09	0.54	0.00
leiomyoma cell line:15425	10571-108B4	21.12	4.13	0.73	4.13	0.73	2.91	1.70	0.24	0.24
leiomyosarcoma cell line:Hs 5.T	10722-110A2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	17.77	4.18	0.00	0.00	1.05	0.00	1.05	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	33.88	2.48	0.83	0.83	0.94	0.47	0.35	0.00	0.24
liposarcoma cell line:KMLS-1	10782-110G8	12.03	0.00	0.47	0.78	0.31	0.94	0.16	0.00	0.00
liposarcoma cell line:SW 872	10726-110A6	16.57	1.83	0.24	0.24	0.73	0.12	0.24	0.00	0.49
liver, adult, pool1	10018-101C9	11.34	0.81	0.49	0.49	0.16	0.49	1.30	12.48	0.00
liver, fetal, pool1	10086-102B5	8.47	0.94	0.94	0.94	0.00	0.94	0.94	2.82	0.00
locus coeruleus - adult, donor10196	10182-103D2	28.14	1.02	0.58	1.46	0.87	0.29	0.73	0.00	0.15
locus coeruleus, adult, donor10252	10165-103B3	31.56	0.37	1.66	1.11	0.18	0.92	0.37	0.18	0.18
locus coeruleus, adult, donor10258	10375-105G6	15.52	0.56	2.26	3.39	0.85	2.82	2.26	0.28	0.28
locus coeruleus, newborn, donor10223	10362-105F2	19.35	0.42	1.26	3.79	0.42	0.42	2.94	0.00	0.00
lung adenocarcinoma cell line:A549	10499-107C4	7.47	1.38	0.69	0.00	0.42	0.28	0.14	0.14	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	4.83	3.45	2.76	0.00	0.00	0.69	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	11.20	1.98	0.40	0.53	0.40	0.26	0.13	0.13	0.13
lung, adult, pool1	10019-101D1	14.65	1.42	1.65	0.71	0.12	0.35	0.59	0.00	0.12
lung, fetal, donor1	10068-101I5	24.55	0.86	2.85	0.86	1.14	0.00	0.00	0.29	0.29
lung, right lower lobe, adult, donor1	10075-102A3	16.50	0.46	0.00	2.29	0.00	0.46	2.29	0.00	0.00
lymph node, adult, donor1	10077-102A5	9.94	0.00	0.47	0.95	0.00	0.47	1.89	0.00	0.00
lymphangiectasia cell line:DS-1	10727-110A7	7.01	0.00	1.53	0.88	0.00	0.00	0.00	0.00	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	11.92	0.00	1.36	0.45	0.30	0.15	0.45	0.00	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	10.19	2.55	0.85	0.85	0.00	0.00	0.00	0.00	0.00
mature adipocyte, donor1	12231-129F8	11.54	0.44	0.89	0.00	0.00	0.00	0.00	0.44	0.00
mature adipocyte, donor2	12232-129F9	14.11	0.00	1.04	0.00	0.00	0.42	0.21	0.21	0.00
mature adipocyte, donor3	12233-129G1	10.90	0.24	0.47	0.00	0.24	0.24	0.00	0.71	0.00
mature adipocyte, donor4	12234-129G2	10.79	0.26	0.79	0.00	0.53	0.79	0.00	0.53	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	19.06	0.00	3.10	0.24	0.24	0.48	0.24	0.24	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	31.58	0.00	1.13	0.00	1.13	0.00	2.26	0.00	1.13
medial frontal gyrus, adult, donor10252	10150-102I6	38.62	1.10	1.10	0.74	0.18	0.18	0.37	0.00	0.00
medial frontal gyrus, adult, donor10258	10368-105F8	28.59	0.00	0.32	1.27	0.32	1.59	0.95	0.00	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	26.44	2.99	0.43	1.71	0.43	0.85	0.85	0.43	1.28
medial temporal gyrus - adult, donor10196	10183-103D3	35.78	0.17	0.34	5.40	0.34	2.19	2.70	0.00	0.00
medial temporal gyrus, adult, donor10252	10156-103A3	47.54	1.27	0.64	1.49	0.42	0.42	0.42	0.21	0.21
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	23.12	0.00	1.93	0.00	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	0.00	28.71	0.00	0.00	14.35	0.00	14.35	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	36.97	1.44	0.36	2.87	0.00	0.72	1.44	0.36	0.00
medulla oblongata - adult, donor10196	10174-103C3	16.22	2.60	0.00	0.65	0.00	0.00	0.00	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	32.35	1.39	1.70	1.24	0.31	0.15	0.93	0.00	0.31
medulla oblongata, adult, pool1	10038-101F2	36.90	1.47	1.55	0.49	1.88	0.41	0.65	0.16	0.98
medulla oblongata, newborn, donor10223	10361-105F1	17.36	0.00	1.74	2.78	0.35	1.04	1.04	0.00	0.00
medulloblastoma cell line:D283 Med	10838-111E1	26.79	0.89	4.43	2.66	6.86	1.99	1.11	0.00	2.44
medulloblastoma cell line:ONS-76	10759-110E3	19.69	1.10	0.24	0.61	0.61	0.24	0.73	0.00	0.49
melanoma cell line:COLO 679	10514-107E1	26.88	0.43	0.29	0.43	0.29	0.43	1.44	0.00	0.29
melanoma cell line:G-361	10465-106H6	19.55	1.63	1.09	2.17	1.09	1.09	3.26	0.00	0.27
meningioma cell line:HKBMM	10691-109F7	16.82	1.45	0.36	1.81	0.72	1.09	1.09	0.18	0.18
merkel cell carcinoma cell line:MKL-1	10843-111E6	46.70	2.64	3.52	7.05	3.52	4.41	1.76	0.00	1.76
merkel cell carcinoma cell line:MS-1	10844-111E7	39.92	1.04	0.52	1.04	1.04	2.59	0.52	0.00	2.33
mesenchymal precursor cell - adipose, donor1	11747-123G1	22.86	1.69	0.31	0.77	0.15	1.07	0.15	0.15	0.61
mesenchymal precursor cell - adipose, donor2	11748-123G2	11.82	1.09	0.36	0.36	0.36	0.91	0.36	0.00	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	13.25	0.00	0.00	2.48	0.00	0.41	0.00	0.00	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	10.68	1.26	1.26	0.70	0.56	0.42	0.14	0.00	0.28
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	10.59	1.35	0.58	0.77	0.77	0.39	0.58	0.00	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	22.21	0.00	0.00	1.39	0.00	2.08	0.00	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	13.90	1.54	0.69	0.69	0.17	0.69	0.86	0.00	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	15.53	2.30	0.00	0.46	0.46	0.69	0.35	0.00	0.00
mesenchymal precursor cell - cardiac, donor3	11754-123G8	17.51	1.33	0.00	0.40	0.40	0.80	0.93	0.13	0.27
mesenchymal precursor cell - cardiac, donor4	11755-123G9	21.07	1.76	0.54	1.08	0.00	0.81	0.27	0.14	0.27
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	15.65	2.85	0.14	1.00	0.00	0.43	0.28	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	12.52	0.66	0.00	0.66	0.99	0.99	0.66	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	16.88	1.66	0.69	0.42	0.00	0.28	0.28	0.14	0.42
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	20.94	4.54	0.00	1.75	0.35	1.75	0.00	0.35	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	18.17	1.84	1.02	0.41	0.00	0.41	0.20	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	8.27	0.72	0.72	0.36	0.00	1.44	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	14.17	3.41	0.21	1.24	0.41	0.41	0.93	0.10	0.10
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	8.44	2.74	0.00	0.46	0.00	0.68	0.68	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	18.04	2.52	0.00	0.00	0.00	0.42	0.84	0.42	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	17.48	1.64	0.00	1.05	0.30	0.90	0.75	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	14.71	1.93	0.61	0.96	0.44	0.53	0.18	0.26	0.18
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	13.62	2.95	0.37	1.10	0.00	0.00	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	12.30	2.86	0.00	1.72	0.29	1.72	0.29	0.00	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	21.89	0.00	0.42	2.53	0.00	2.95	0.84	0.00	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	11.42	1.83	0.00	0.00	0.46	0.00	0.00	0.00	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	16.63	1.53	0.00	0.26	0.51	0.51	0.26	0.00	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	13.61	2.09	0.52	0.52	0.00	0.26	1.05	0.00	0.52
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	16.33	0.92	0.92	0.00	0.92	0.92	0.31	0.00	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	13.65	0.94	0.24	0.47	0.47	0.94	0.47	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	16.58	3.05	1.35	0.68	0.68	1.35	0.68	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	17.29	1.18	0.39	0.39	0.79	0.00	0.00	0.00	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	14.36	1.85	0.46	0.46	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	16.15	1.15	0.00	0.29	1.44	1.15	0.58	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	16.06	1.34	0.45	0.89	1.34	0.00	0.00	0.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	17.06	0.96	0.48	0.24	0.48	0.48	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	16.87	0.00	0.73	0.73	0.73	1.47	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	14.43	1.34	0.34	1.01	0.34	0.34	0.67	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	11.87	0.41	0.00	0.82	0.82	0.41	0.41	0.00	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	15.03	0.86	0.43	0.86	0.43	0.86	0.43	0.86	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	5.47	2.73	0.00	0.00	0.00	2.73	2.73	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	5.16	0.00	0.00	5.16	0.00	0.00	0.00	0.00	5.16
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	13.64	0.65	0.00	0.97	0.00	1.30	0.00	0.32	0.65
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	10.18	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	16.53	0.53	0.00	1.07	1.07	1.07	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	12.27	0.00	0.00	0.00	0.82	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	10.88	1.17	0.39	0.00	0.39	0.78	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	12.59	4.20	0.00	0.00	0.00	6.30	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	6.95	0.99	0.00	2.98	0.00	0.99	0.00	0.00	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	4.77	0.00	0.00	0.00	0.00	4.77	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	12.45	0.59	0.00	0.59	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	12.18	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	12.03	1.27	0.00	0.63	0.63	1.27	1.27	0.00	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	11.38	1.38	0.69	0.00	0.34	0.34	0.00	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	15.04	0.00	0.00	2.15	0.00	2.15	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	7.98	3.99	3.99	0.00	3.99	0.00	0.00	0.00	3.99
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	6.89	3.44	0.00	0.00	0.00	3.44	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	9.78	2.85	0.00	0.81	0.81	0.00	0.41	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	11.12	3.18	0.00	0.00	0.79	0.79	0.79	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	11.79	0.59	0.59	1.77	0.00	0.00	1.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	8.73	0.94	0.94	0.00	1.87	0.31	0.31	0.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	13.37	1.34	1.34	0.00	1.34	1.34	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	8.28	1.18	0.00	0.00	1.18	1.18	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	7.70	0.00	0.00	0.00	0.00	0.00	2.57	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	8.26	0.69	0.69	0.00	0.00	0.69	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	10.39	0.00	0.99	0.49	0.49	0.49	0.00	0.49	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	8.97	0.00	0.00	1.12	0.00	2.24	1.12	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	5.72	0.00	0.64	0.00	0.64	0.64	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	13.30	0.40	0.00	0.81	0.00	0.81	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	4.36	2.18	0.00	0.00	0.00	2.18	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	11.40	0.00	1.27	0.00	0.00	1.27	1.27	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	5.46	0.00	0.61	0.00	0.00	0.61	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	13.56	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	8.24	0.00	1.65	0.82	0.00	1.65	0.82	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	5.75	0.20	0.40	0.20	0.20	0.00	0.20	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	9.09	0.00	0.65	0.00	0.00	0.65	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	9.17	1.02	0.00	1.02	0.00	0.00	0.00	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	11.61	0.77	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	9.92	2.13	0.00	0.71	0.24	0.47	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	10.43	9.27	0.70	0.23	0.70	0.00	0.00	0.70	0.46
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	21.37	0.00	0.00	0.00	0.00	4.27	0.00	0.00	4.27
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	9.86	3.08	0.21	1.34	0.82	0.51	0.92	0.00	0.82
mesothelioma cell line:Mero-25	10850-111F4	7.49	2.27	0.45	1.13	0.68	0.23	0.00	0.00	1.82
mesothelioma cell line:Mero-41	10851-111F5	17.36	0.98	0.00	1.22	0.49	0.24	0.24	0.00	0.00
mesothelioma cell line:Mero-48a	10852-111F6	16.61	0.89	0.44	0.44	0.44	0.44	0.89	0.00	0.66
mesothelioma cell line:Mero-82	10853-111F7	12.09	4.20	0.26	1.05	0.79	0.26	0.00	0.00	1.05
mesothelioma cell line:Mero-83	10854-111F8	18.38	3.92	1.02	1.36	1.36	0.68	0.85	0.00	0.34
mesothelioma cell line:Mero-84	10855-111F9	7.08	1.52	0.00	0.51	0.00	0.51	0.51	0.00	0.51
mesothelioma cell line:Mero-95	10856-111G1	12.22	5.38	0.21	1.04	0.41	1.04	1.04	0.00	0.62
mesothelioma cell line:NCI-H2052	10847-111F1	8.45	0.00	0.17	0.33	0.17	0.50	0.17	0.00	0.00
mesothelioma cell line:NCI-H226	10846-111E9	7.42	1.09	0.36	0.18	0.18	0.36	0.36	0.18	0.18
mesothelioma cell line:NCI-H2452	10848-111F2	15.54	2.73	1.02	1.20	1.71	0.00	0.17	0.00	1.54
mesothelioma cell line:NCI-H28	10845-111E8	13.23	0.00	1.02	1.02	2.29	0.25	0.51	0.00	0.51
mesothelioma cell line:No36	10857-111G2	13.37	1.63	0.65	0.65	0.98	0.33	0.33	0.00	0.00
mesothelioma cell line:ONE58	10858-111G3	18.97	0.81	0.00	0.81	0.27	0.81	0.27	0.00	0.00
migratory langerhans cells, donor1	11901-125F2	12.28	0.00	1.54	1.34	0.00	0.00	0.19	0.00	0.00
migratory langerhans cells, donor2	11902-125F3	12.21	0.12	0.61	0.49	0.00	0.37	0.24	0.00	0.00
migratory langerhans cells, donor3	11903-125F4	10.41	0.36	1.79	0.36	0.90	0.36	0.00	0.00	0.18
mixed mullerian tumor cell line:HTMMT	10689-109F5	16.00	2.61	0.33	3.92	1.96	1.31	1.31	0.00	0.65
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	7.63	2.12	0.21	0.42	0.21	1.27	0.00	0.00	0.21
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	9.68	2.07	0.00	0.69	0.23	0.00	0.00	0.00	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	7.80	0.00	0.76	0.38	0.38	0.38	0.57	0.00	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	33.82	0.00	8.13	1.85	0.18	0.74	0.74	0.00	0.00
myeloma cell line:PCM6	10474-106I6	15.02	0.00	3.56	1.19	0.59	0.79	0.59	0.00	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	15.73	4.06	0.51	0.00	0.00	0.00	0.00	0.00	0.51
myxofibrosarcoma cell line:NMFH-1	10684-109E9	17.85	1.57	2.55	0.59	0.20	0.00	0.39	0.00	0.20
nasal epithelial cells, donor1, tech_rep1	12226-129F3	6.13	1.45	1.67	0.22	0.67	0.00	0.00	0.00	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	5.66	1.99	1.62	0.29	0.37	0.07	0.15	0.00	0.07
nasal epithelial cells, donor2	12227-129F4	7.73	1.10	0.55	0.55	0.00	0.00	0.00	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	31.29	0.46	10.35	0.69	16.79	0.00	0.23	0.00	4.83
neuroblastoma cell line:NB-1	10539-107G8	43.22	2.99	0.94	1.12	1.87	0.00	0.75	0.19	1.12
neuroblastoma cell line:NBsusSR	10607-108F4	25.10	1.27	1.05	1.05	0.42	0.42	0.84	0.00	1.27
neuroblastoma cell line:NH-12	10555-107I6	34.47	0.37	4.66	1.49	7.83	0.75	0.56	0.00	2.42
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	20.64	1.42	1.19	2.37	3.80	0.95	1.42	0.00	1.19
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	17.26	1.11	0.32	1.11	1.27	1.58	1.74	0.00	1.11
neuroectodermal tumor cell line:TASK1	10774-110F9	18.31	0.40	1.21	2.01	2.82	0.40	0.20	0.00	2.01
neuroepithelioma cell line:SK-N-MC	10728-110A8	17.80	1.27	0.00	0.64	0.00	0.00	0.00	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	15.17	0.53	0.53	0.53	0.00	0.80	0.53	0.00	0.27
neutrophil PMN, donor1	12133-128D9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	0.00	13.28	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	16.74	0.00	4.57	0.51	2.03	0.68	0.17	0.00	0.51
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	20.81	0.80	0.00	0.00	0.80	0.00	0.00	0.00	0.80
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	16.03	4.49	0.64	2.24	0.32	0.32	1.28	0.00	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	17.34	0.79	0.53	1.84	0.26	3.68	1.05	0.00	0.26
nucleus accumbens, adult, pool1	10037-101F1	47.34	1.22	1.59	1.12	1.03	0.47	0.47	0.09	0.56
occipital cortex - adult, donor10196	10172-103C1	18.54	2.06	0.00	0.00	0.00	0.00	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	48.57	2.15	1.07	1.61	0.81	0.81	0.54	0.00	0.00
occipital cortex, newborn, donor10223	10355-105E4	46.95	1.09	0.36	2.18	0.36	1.46	0.73	0.36	0.36
occipital lobe, adult, donor1	10076-102A4	39.88	0.26	0.00	2.62	0.79	2.10	3.67	0.00	0.79
occipital lobe, fetal, donor1	10073-102A1	51.92	0.86	0.00	4.29	1.29	0.43	4.29	0.00	0.86
occipital pole, adult, pool1	10036-101E9	47.62	1.58	0.47	1.42	0.79	0.55	0.39	0.08	0.55
olfactory region, adult	10195-103E6	39.93	0.57	0.76	2.10	0.19	0.76	1.34	0.00	0.19
optic nerve, donor1	10277-104E7	30.02	4.00	0.00	4.00	0.00	2.00	4.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	18.23	1.48	2.62	0.46	0.57	0.23	1.03	0.00	0.11
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	8.93	0.96	0.69	0.41	1.79	0.27	0.14	0.00	0.82
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	14.90	3.05	0.34	1.19	0.00	1.35	0.51	0.00	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	8.66	0.35	0.23	0.58	0.23	0.23	0.23	0.00	0.58
osteoclastoma cell line:Hs 706.T	10704-109H2	18.81	0.29	0.00	0.59	0.29	0.29	0.59	0.00	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	14.95	1.87	1.87	0.00	0.00	0.00	0.00	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	22.48	0.42	1.70	0.42	1.70	0.21	0.64	0.00	0.85
ovary, adult, pool1	10020-101D2	19.74	7.16	1.31	1.40	1.14	0.52	1.05	0.09	0.70
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	17.42	1.47	0.73	0.73	0.00	0.37	0.37	0.00	0.00
pancreas, adult, donor1	10049-101G4	16.93	1.88	0.00	0.94	0.00	1.88	0.00	0.94	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	18.17	8.11	1.12	1.96	0.28	1.40	1.40	0.56	0.56
papillary adenocarcinoma cell line:8505C	10437-106E5	18.57	1.36	0.68	2.04	0.68	1.87	0.68	0.17	0.51
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	9.60	0.83	1.99	0.99	0.99	0.33	0.50	0.17	0.17
paracentral gyrus, adult, pool1	10035-101E8	46.77	1.83	0.73	0.82	0.73	0.64	0.73	0.27	0.46
parietal cortex, adult, donor10258	10373-105G4	27.89	0.73	0.73	0.00	0.00	0.73	1.47	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	19.75	0.00	0.00	0.00	0.94	0.94	0.94	0.00	0.94
parietal lobe, adult, donor10252	10157-103A4	41.33	1.71	0.86	2.28	0.00	0.00	0.57	0.00	0.29
parietal lobe, adult, pool1	10034-101E7	48.20	1.32	1.59	1.06	0.70	0.62	0.62	0.18	0.79
parietal lobe, fetal, donor1	10072-101I9	40.73	0.00	0.97	2.91	1.94	4.85	1.94	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	35.89	0.37	0.75	3.36	0.00	1.12	1.12	0.00	0.37
parotid gland, adult	10199-103F1	27.13	0.00	4.93	0.00	0.62	1.23	0.00	0.00	0.00
penis, adult	10200-103F2	13.96	3.76	0.54	2.69	0.54	0.00	0.00	0.00	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	14.32	0.00	1.12	1.49	4.28	1.30	1.30	0.00	3.16
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	11.95	0.29	0.73	0.29	0.00	0.58	0.29	0.00	0.00
pineal gland - adult, donor10196	10179-103C8	32.90	0.00	1.94	1.29	0.00	0.00	0.65	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	41.45	1.18	7.11	1.78	0.59	1.18	0.00	0.00	0.59
pineal gland, adult, donor10258	10377-105G8	30.10	0.00	2.51	0.63	0.00	0.00	1.25	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	24.28	0.00	1.01	1.01	0.00	1.01	2.02	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	19.80	2.61	1.56	1.04	1.04	0.52	0.52	0.00	0.00
pituitary gland, adult, donor10258	10378-105G9	13.62	1.70	1.70	0.00	2.55	0.00	0.85	0.00	0.00
placenta, adult, pool1	10021-101D3	17.95	2.37	0.65	0.65	0.32	0.32	0.22	0.11	0.11
plasma cell leukemia cell line:ARH-77	10840-111E3	12.71	0.00	0.93	0.00	0.13	0.53	0.13	0.00	0.13
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	25.68	0.78	0.31	0.16	0.16	0.62	0.00	0.00	0.00
pons, adult, pool1	10033-101E6	36.66	2.50	0.95	1.38	1.20	0.43	0.26	0.17	0.86
postcentral gyrus, adult, pool1	10032-101E5	46.38	1.57	0.96	0.87	0.96	1.05	0.17	0.17	0.26
promyelocytes/myelocytes PMC, donor1	12132-128D8	16.73	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	5.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	26.95	2.91	3.64	3.06	1.31	1.31	1.02	0.00	0.87
prostate cancer cell line:PC-3	10439-106E7	23.41	0.18	1.27	1.63	0.18	0.54	0.36	0.36	0.18
prostate, adult, pool1	10022-101D4	19.23	4.35	1.45	1.27	0.63	0.18	0.27	0.00	0.27
putamen, adult, donor10196	10176-103C5	68.22	3.54	0.00	2.12	0.71	1.18	0.94	0.00	0.24
putamen, adult, donor10252	10152-102I8	29.41	3.92	0.00	0.00	0.00	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	10.93	3.28	1.09	1.09	1.09	0.00	0.00	0.00	1.09
putamen, adult, donor10258, tech_rep2	10372-105G3	27.06	2.66	0.00	1.69	0.72	1.69	0.24	0.00	0.00
putamen, newborn, donor10223	10365-105F5	19.49	0.75	0.00	1.50	0.00	0.75	1.50	0.75	0.00
rectal cancer cell line:TT1TKB	10469-106I1	8.73	0.58	0.00	0.29	0.00	0.00	0.00	1.16	0.00
rectum, fetal, donor1	10067-101I4	16.69	2.78	0.00	1.39	1.39	0.00	1.39	0.00	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	14.42	0.64	0.64	0.42	0.00	0.85	0.64	0.21	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	10.36	1.66	0.00	2.07	0.00	1.24	0.83	0.00	0.00
retina, adult, pool1	10030-101E3	30.62	2.48	3.68	1.19	0.89	0.50	0.50	0.30	0.30
retinoblastoma cell line:Y79	10475-106I7	41.05	1.04	6.50	1.56	19.49	1.04	1.04	0.00	2.60
rhabdomyosarcoma cell line:KYM-1	10787-110H4	35.53	4.92	0.74	1.11	3.32	0.37	0.37	0.74	3.69
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	25.03	1.12	1.69	1.69	3.37	0.84	0.00	0.00	0.84
sacrococcigeal teratoma cell line:HTST	10695-109G2	15.91	4.55	0.76	0.76	0.00	0.00	0.00	0.00	0.00
salivary acinar cells, donor1	11771-123I7	12.30	5.50	0.81	0.32	0.65	0.49	0.32	0.16	0.32
salivary acinar cells, donor2	11772-123I8	13.08	6.20	1.38	0.69	2.89	0.83	1.51	0.14	0.41
salivary acinar cells, donor3	11773-123I9	7.28	7.28	0.66	0.00	0.66	0.00	0.00	0.00	1.32
salivary gland, adult, pool1	10093-102C3	12.58	1.14	1.72	0.00	0.00	1.72	0.00	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	14.33	3.12	0.93	0.93	4.38	0.34	0.42	0.00	1.52
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	11.99	4.23	0.35	0.47	4.94	0.12	1.06	0.12	2.23
seminal vesicle, adult	10201-103F3	27.51	4.76	1.06	3.70	2.12	1.06	1.59	0.00	0.53
serous adenocarcinoma cell line:JHOS-2	10639-108I9	14.33	0.73	4.13	0.49	0.00	0.97	0.24	0.24	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	8.81	0.00	0.75	0.25	0.25	0.25	0.00	0.00	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	16.06	0.00	0.00	2.01	0.00	2.01	1.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	11.55	0.27	2.42	0.67	0.54	0.81	0.00	0.00	0.00
signet ring carcinoma cell line:Kato III	10436-106E4	16.03	0.11	0.99	0.44	0.00	0.33	0.33	0.00	0.00
signet ring carcinoma cell line:NUGC-4	10483-107A6	9.55	0.77	0.00	0.39	0.77	0.13	0.13	1.42	0.13
skeletal muscle - soleus muscle, donor1	10282-104F3	12.06	7.80	0.00	2.84	0.00	0.00	2.13	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	20.27	1.80	2.28	0.60	0.00	0.36	0.96	0.00	0.00
skeletal muscle, fetal, donor1	10066-101I3	13.07	0.00	3.02	0.00	2.01	1.01	0.00	0.00	0.00
skin, adult, donor1	10074-102A2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	19.57	0.63	3.16	2.52	0.63	0.63	3.16	0.00	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	38.69	4.34	0.67	1.00	0.00	0.33	0.67	0.33	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	26.16	1.89	0.63	4.10	5.36	1.58	2.52	0.00	6.62
small cell lung carcinoma cell line:DMS 144	10841-111E4	53.78	0.00	2.51	2.89	0.39	1.73	0.96	0.00	0.58
small cell lung carcinoma cell line:LK-2	10541-107H1	20.77	0.49	2.47	0.16	1.48	0.16	0.00	0.00	0.82
small cell lung carcinoma cell line:NCI-H82	10842-111E5	18.82	0.32	3.38	0.80	5.47	0.16	0.32	0.00	1.61
small cell lung carcinoma cell line:WA-hT	10562-108A4	31.82	2.83	0.00	1.74	2.62	0.87	0.22	0.87	2.83
small intestine, adult, pool1	10024-101D6	19.59	4.06	0.24	2.75	0.72	1.67	2.87	75.37	0.12
small intestine, fetal, donor1	10064-101I1	20.88	0.49	0.00	4.42	0.49	0.98	2.95	26.04	0.00
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	46.16	1.03	4.10	3.59	0.51	4.10	0.51	0.51	0.00
smooth muscle, adult, pool1	10048-101G3	13.96	10.60	0.52	0.52	1.29	0.26	1.29	0.00	0.26
somatostatinoma cell line:QGP-1	10781-110G7	19.57	0.27	0.27	1.07	0.27	0.54	0.54	0.27	0.00
spinal cord - adult, donor10196	10181-103D1	24.09	1.15	0.46	0.92	2.06	0.92	0.92	0.23	0.69
spinal cord, adult, donor10252	10159-103A6	18.14	0.79	1.97	0.39	2.37	0.00	1.58	0.00	0.39
spinal cord, adult, donor10258	10369-105F9	7.61	0.69	0.69	0.00	0.00	0.69	2.08	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	58.54	0.00	1.22	6.71	0.61	1.22	2.44	0.61	1.22
spinal cord, newborn, donor10223	10359-105E8	11.02	0.46	0.46	2.30	0.46	1.84	0.00	0.00	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	17.03	1.05	0.00	0.15	0.00	0.30	0.75	0.00	0.00
spleen, adult, pool1	10025-101D7	15.09	0.33	1.10	0.55	0.00	0.44	0.55	0.00	0.11
spleen, fetal, pool1	10044-101F8	18.59	0.08	1.59	0.48	0.56	0.48	0.16	0.00	0.16
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	11.08	0.00	1.55	0.52	0.41	0.00	0.00	0.10	0.10
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	3.80	1.90	0.19	0.19	0.38	0.00	0.00	0.00	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	22.36	2.45	1.75	3.84	0.00	2.10	1.05	0.00	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	12.90	2.74	0.78	0.78	0.00	0.39	0.78	0.00	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	22.96	2.14	3.15	1.35	0.23	0.45	0.56	0.11	0.23
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	19.06	0.00	0.85	3.39	0.00	0.85	0.00	0.00	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	25.38	0.00	0.00	0.42	0.42	0.42	0.85	0.42	0.00
stomach, fetal, donor1	10062-101H8	20.29	1.07	0.00	1.07	0.00	0.00	0.00	0.00	1.07
submaxillary gland, adult	10202-103F4	20.51	0.00	1.14	0.57	0.00	0.00	1.14	0.00	0.00
substantia nigra - adult, donor10196	10178-103C7	54.27	0.00	0.00	0.00	0.00	0.00	54.27	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	27.00	1.66	1.87	1.87	2.91	0.42	1.04	0.00	0.62
substantia nigra, adult, donor10258	10371-105G2	15.00	0.00	0.52	0.52	0.00	1.03	0.00	0.00	0.52
substantia nigra, newborn, donor10223	10358-105E7	24.73	0.00	0.71	0.71	0.00	1.41	2.12	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	34.85	5.96	0.46	1.60	3.21	0.92	0.69	0.00	0.92
temporal lobe, adult, pool1	10031-101E4	51.12	0.76	0.68	1.44	0.85	0.76	0.42	0.17	0.42
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	61.97	0.00	1.42	3.56	0.00	2.85	0.71	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	40.00	0.00	0.88	3.96	0.88	0.88	1.32	0.00	0.00
tenocyte, donor1	11763-123H8	23.74	1.40	0.35	2.44	0.70	3.84	0.35	0.35	0.35
tenocyte, donor2	11765-123I1	16.79	0.76	0.00	1.53	0.00	1.14	0.38	0.00	0.00
tenocyte, donor3	11768-123I4	17.42	1.11	1.85	2.22	0.00	2.22	1.48	0.00	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	26.85	1.87	0.85	1.53	2.04	1.53	0.68	0.00	1.70
teratocarcinoma cell line:NCR-G1	10798-110I6	17.73	0.31	0.62	1.54	0.00	1.23	1.08	0.62	0.92
teratocarcinoma cell line:PA-1	10807-111A6	19.22	0.46	0.46	1.39	2.63	0.00	0.62	0.15	2.48
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	31.48	2.29	3.17	1.27	2.54	0.38	2.41	0.00	3.30
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	17.02	7.94	1.51	0.76	6.43	0.38	1.51	0.00	4.92
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	13.96	6.22	2.40	0.76	1.42	0.98	0.44	0.22	1.09
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	20.84	1.63	1.30	1.30	1.95	1.63	0.98	0.00	0.98
testis, adult, pool1	10026-101D8	32.43	2.04	0.97	3.54	0.75	1.40	5.58	0.11	0.64
testis, adult, pool2	10096-102C6	50.52	1.80	0.45	4.06	0.00	3.16	2.26	0.00	0.00
thalamus - adult, donor10196	10168-103B6	22.08	0.00	1.10	0.00	0.00	1.10	1.10	0.00	0.00
thalamus, adult, donor10252	10154-103A1	35.32	1.25	2.34	1.09	0.63	0.94	0.31	0.00	0.31
thalamus, adult, donor10258, tech_rep1	10370-105G1	21.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	14.00	0.66	0.49	2.47	0.33	1.65	3.29	0.00	0.33
thalamus, newborn, donor10223	10366-105F6	43.15	0.00	0.00	2.30	0.00	0.58	1.15	0.00	0.00
throat, adult	10209-103G2	17.73	1.00	0.75	1.25	0.50	0.50	0.50	0.00	0.50
throat, fetal, donor1	10061-101H7	19.81	0.91	2.44	1.83	1.22	0.00	0.30	0.00	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	29.61	1.79	4.57	0.79	5.76	1.19	0.99	0.00	1.99
thymus, adult, pool1	10027-101D9	18.79	0.20	2.09	1.19	0.80	0.70	1.19	0.00	0.10
thymus, fetal, pool1	10043-101F7	22.55	0.73	2.29	1.56	1.25	0.21	0.31	0.00	0.73
thyroid carcinoma cell line:KHM-5M	10776-110G2	19.01	0.80	0.53	1.73	0.27	0.53	1.33	0.00	0.27
thyroid carcinoma cell line:TCO-1	10783-110G9	16.48	0.56	0.84	0.84	0.14	0.28	0.70	0.14	0.28
thyroid, adult, pool1	10028-101E1	28.27	1.49	2.43	1.49	0.56	0.56	0.93	0.00	0.09
thyroid, fetal, donor1	10060-101H6	24.78	2.11	1.05	2.64	0.00	1.32	1.32	0.00	0.79
tongue epidermis (fungiform papillae), donor1	10288-104F9	15.40	9.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00
tongue, adult	10203-103F5	12.09	0.23	0.70	1.40	0.23	0.93	0.47	0.47	0.00
tongue, fetal, donor1	10059-101H5	14.19	1.58	0.39	1.97	0.00	0.00	1.18	0.00	0.39
tonsil, adult, pool1	10047-101G2	14.02	0.50	2.00	0.60	0.10	0.10	0.00	0.00	0.10
trachea, adult, pool1	10029-101E2	15.05	2.04	1.80	0.41	0.57	0.08	0.82	0.00	0.25
trachea, fetal, donor1	10058-101H4	18.85	1.54	1.92	0.00	0.00	0.00	0.77	0.00	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	11.34	2.13	0.00	0.71	0.00	0.35	1.06	0.00	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	14.79	1.82	0.61	0.91	1.01	0.30	0.41	0.00	0.51
transitional-cell carcinoma cell line:JMSU1	10492-107B6	18.18	10.03	0.78	0.94	3.60	1.10	2.04	0.16	1.57
tridermal teratoma cell line:HGRT	10694-109G1	11.42	9.51	1.90	0.00	0.00	1.90	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	15.49	3.47	1.27	0.85	1.95	0.34	0.85	0.42	0.34
umbilical cord, fetal, donor1	10057-101H3	20.87	0.00	2.09	0.00	0.00	0.00	2.09	0.00	2.09
uterus, adult, pool1	10100-102D1	23.21	1.88	0.68	0.85	0.17	0.34	0.34	0.17	0.68
uterus, fetal, donor1	10055-101H1	31.23	0.00	2.05	0.51	1.02	1.02	0.00	0.00	0.51
vagina, adult	10204-103F6	12.28	1.94	2.58	0.00	0.00	1.94	0.00	0.00	0.00
vein, adult	10191-103E2	16.22	0.44	0.22	1.10	0.44	0.22	0.88	0.22	0.44
xeroderma pigentosum b cell line:XPL 17	10563-108A5	8.55	0.00	1.60	0.00	0.53	0.27	0.00	0.00	0.00